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ABSTRACT 
Chapter one reviews the literature published on the 
pseudomonic acids. The chemistry and structural 
characteristics of these compounds is covered together with 
the semi-synthetic modifications which have been 
investigated to enhance their anti-bacterial properties. 
Some of the synthetic routes to pseudomonic acid C are 
reviewed along with its subsequent conversion to pseudomonic 
acid"A. The previous biosynthetic studies are described in 
detail. 
Chapter two briefly reviews the use and methods of detection 
of radioactive and stable isotopes in biosynthetic studies. 
The maintance of the P. fluorescens culture and the 
conditions for the production and isolation of the 
metabolites are described. Intial incorporation experiments 
using [l-13C, 
1802]acetate, [1-13C, 2H3]acetate and 
1802 
gas 
are discussed and the results from these experiments allow 
for mechanisms for the formation of the pyran ring and 




13C2 labelled forms of 
ß-hydroxy-ß-methyl glutarate and its non-intact 
incorporation into pseudomonic acid is discussed. The 
synthesis of 
13C labelled malonate and the results of its 
incorporation into pseudomonic acid are described and 
indicate that malonate is an important precursor. 
Differential levels of enrichment were observed with 
malonate going preferentially into the 9-hydroxynonanoic 
iv 
acid side chain. 
In chapter three, a stepwise mechanism for the formation of 
pseudomonic acid is proposed and discussed. The synthesis 
of three of the proposed chain assembly intermediates, ie. 
acetoacetate; (2S, 3S)-3-hydroxy-2-methylbutanoic acid and 
5-hydroxy-4-methylhex-2-enoic acid are described. Results of 
intial incorporation studies using 5% 
2H20 in the culture 
medium and [2-2H3]acetate are detailed together with the 
attempted incorporation of 
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Pseudomonic Acid D (6) 
Introduction 
1.1 CHEMISTRY AND STRUCTURE 
Fermentation of Pseudomonas fluorescens (NCIB 10568) 
produces a group of novel antibiotics collectively known as 
the pseudomonic acids1. They are now being used clinically 
under the generic name "mupirocin" for the topical treatment 
of skin infections. The therapeutic value of these 
antibiotics has been clinically developed by Bee. cham2. They 
function as competitive inhibitors of isoleucyl-t-RNA 
synthetase3 and are effective antimicrobical agents against 
Gram positive bacteria and mycoplasmal pathogens. Cross 
resistance with other commonly used antibiotics is not 
observed and they' are also effective against multiple 
strains of 
Staphylococcus aureus 
Detailed studies of their chemical and structural 
characteristics have been fully reported in a series of 
papers4. The major metabolite, pseudomonic acid A (1) has a 
complex structure consisting of: a C17 unsaturated 
carboxylic acid moiety (2), known as monic acid, containing 
epoxide, diol and tetrahydropyran ring functions which has 
been esterified by an unique 9-hydroxynonanoic acid moiety 
(3), as shown in scheme 1.1. 
The minor metabolites, designated pseudomonic acids B (4), C 
(5), and D (6), all possess this basic nucleus of monic acid 
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Aurantinin A (10) 










Myxopyronin A (12) R=CH CH CH 
Myxopyronin B (13) Ra(C 2)3CH3 3 
C-8; C has a trans carbon-carbon double bond in place of the 
epoxide at C-9 and D has a trans carbon-carbon double bond 
at C-4' in the 9-hydroxynonanoic acid side chain. 
Classification on a structural basis with any of the known 
antibiotic groups5 is not really possible. The nearest 
relatives of pseudomonic acid are perhaps, the. polycyclic 
polyether monocarboxylic acids such as monensin (7), 
nigericin (8) and alborixin (9). These compounds function as 
antibiotics by influencing cation transport across 
membranes. Other bacterial metabolites which possess 
antibacterial antibiotic activity are, for example, the 
aurantinins A and Bs` (10) and (11). Like pseudomonic acid 
they are polyketide derived with the basic biological 
precursors being acetate and methionine. Again, the 
presence of a methyl group formed by decarboxylation of 
acetate is found and is common with pseudomonic acid and the 
myxopyronines A and B24 (12) and (13) which are all true 
bacterial metabolites. 
Chain and Mellows' observed that the antibiotic activity of 
pseudomonic acid A in solution was dependent on pH. 
Activity was retained within the range pH 4-9 but was 
gradually lost outside these limits. The acid and base 
catalysed rearrangement products derived by intramolecular 
opening of the epoxide ring, have been shown to be the 
trans-fused bicyclic structures7'8 (14) and (15). Scheme 
1.2, illustrates the mechanisms for the formation of these 
rearrangement products. Hence, these compounds are isomeric 















































































assignments have been published recently9. In view of the 
interest in pseudomonic acid as a novel antibiotic, this 
chemical instability to acid and alkali has been 
investigated7' It was found-that in acid solution (pH 1.0) 
rearrangement was complete within 30 minutes. However, in 
alkaline solution (pH 13.0) rearrangement was much slower 
with only 30% rearrangement observed after 30 minutes. It 
was complete after 18 hours. 
No interconversion between these two isomeric compounds was 
observed when these rearrangement products were subjected to 
the same acidic and basic conditions of the rearrangement 
reactions. Therefore, these rearrangement isomers are 
derived from monic acid by two competing mechanisms in which 
the relative rates of intramolecular rear side attack of the 
7-hydroxy group on the epoxide carbons 10 and 11 are 
dependent on the reaction conditions. In these studies, 
monic acid was used to avoid complications arising from the 
hydrolysis of the unsaturated ester. 
The effect of chemical modification 
2'4'8 
on the biological 
properties of pseudomonic acid has also been investigated. 
When given systemically to mammalian species, including man, 
it is rapidly metabolised with loss of antibacterial 
activity. Another unfavourable characteristic of 
pseudomonic acid is its degree of binding to serum protein. 
It binds to the extent of 95% to human serum protein and 
since it is only the unbound portion of the antibiotic that 
is free to exert any antibacterial action, chemical 
modification to try to reduce this high degree of binding 
3 
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(18) R-(CH 2)8CO2Me 
(19) R=Me 
(20) R'Etn 
(21) R BU 
was investigated. 
In general, the degree of protein binding appears to 
correlate with lipophilicity. Hence, one approach used was 
to reduce the lipophilicity of pseudomonic acid by replacing 
the 9-hydroxynonanoic acid side chain with shorter chain 
alcohols. Methyl monate (16) was significantly less protein 
bound (30% bound) and it was also antibacterially active 
with a spectrum of activity similar to that of pseudomonic 
acid. The un-natural isomers, methyl iso-monate (17) and 
methyl iso-pseudomonate (18) were 100-fold less active than 
the corresponding natural trans forms. 
Interestingly, monic acid (2) which is the nucleus of all 
the pseudomonic acids exhibits no antibacterial activity 
7 
With suitable protection and deprotection, the 
9-hydroxynonanoate side chain can be cleaved and the 
resulting monic acid nucleus can then be used to generate a 
wide variety of esters. Apart from the esters mentioned 
previously none of these synthetic analogues showed 
antibacterial activity. 
The biological properties of aß-unsaturated ketones4(d), 
prepared from monic acid have also been investigated. Only 
three ketones (19), (20) and (21) of the group prepared 
displayed interesting antimicrobial activity. 
To try to reduce the rate of metabolic cleavage of the 
allylic ester, effects of substitution at C-2 was 



































substituents were tried. The synthetic approaches to these 
analogues are outlined in scheme 1.3. 
(i) Addition of X-Y to an allylic ester followed by 
displacement of X then elimination of H-Y. 
(ii) Hydrogenation, alkylation and electrophilic 
substitution with X+ followed by 
elimination of H-X. 
However, neither of these approaches were successful. 
(iii) Peterson olefination works. 
(iv) Electrophilic addition to dienolates. Both of these 
approaches work and are of practical value. 
Anions derived from 2-substituted phosphonoacetates 
generally did not react except for ethyl 2-fluoro 
phosphonoacetate, which gave good yields of ethyl 
2-fluoromonate and its isomer. Anions of a-substituted 
silyl esters react efficiently with the ketone in route 
(iii) but stereoselectivity was found to be highly in favour 
of the biologically inactive isomonate esters. 
Antimicrobial activity was found in only the 2-fluoro and 
the 2-methyl monate esters. 
Additional work on route (iv)4(d) was used to insert 
substituents at C-15 as well as at C-2. This was achieved 
by use of lithium dienolates (22). The hydroxyl groups of 
monic acid were first protected as trimethylsilyl ethers. 
Electrophilic addition can occur at either the 'hard' 
nucleophilic a position (C-2) or at the 'soft' nucleophilic 























R groups varied as follows: 
R1= Me, Et 
R2= H, Me, Et, PhS, MeS, PhCH2, D 
R3- H, SiMe3 
R4- H, D, SiMe31 PhS, PhSe 






R groups varied as follows: 
R1- MeO, H, MeS 
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(29) (13-amino. derivative) 
the nature of the nucleophile. Addition to the a-position 
provides the diastereoisomeric deconjugated esters (23) 
whilst addition to the alternative i-position affords 
mixtures of the conjugated esters (24) and (25) in varying 
ratios according to the electrophile. 
Results of this study, showed that only esters of 
2-fluoromonic acid and 2-methylmonic acid possessed 
significant antibacterial and antimycoplasmal activity. 
Esters of 2-fluoromonic acid offered no advantages in 
metabolic activity. However, esters of 2-methylmonic acid 
did show significant increases in stability in tissue 
homogenates and in vivo . over analogous esters of monic 
acid. No antimicrobial activity was observed from either 
the deconjugated esters or the dihydropyrones (26) prepared 
from them. 
Finally, a report of more recent work10, on the effects of 
chemical modification of the pseudomonic acids details the 
effects of reduction, inversion and replacement of the C-13 
hydroxyl group, with an amino group. It was known the deoxy 
deriviative (27), could not be formed in the presence of 10, 
11 epoxide and so was replaced by a carbon-carbon double 
bond. Also, for the formation of the amine deriviative, it 
was necessary to carry out the transformation on the 
pseudomonic acid C series because the reduction step, oxime 
to amine, also resulted in the reduction of the ester and 
epoxide functions. The results of this study were that the 
13-deoxy compound (27), methyl (13R)-monate (28) and the 
13-amino-deriv. a Live (29) displayed little antimicrobial 
6 
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-º OH + 
HO 
H HO H 
(37) (38) 
Scheme 1.4 
Reagents: (a) Trityl chloride (1.1 equiv), DMAP (1.1 equiv), 
DMF (b) NaH dispersion, 'HF, benzyl bromide (83%) (c) 
40% conc. HC1 in methanol, 220C, 14h (84%) (d) PPTS (0.1 
equiv), acetone, 18h, (77%) (e) CICOCOCI (1.5 equiv), Me SO 
(2.4 equiv), CHý2C1 , -78 C; " then Et N (2.4 equiv), -78°C-? 0°C (87%) (f) 9-BBzt tsýiflate, Et 0, Mo ester 33 Ji equiv), 
diisopropylamine (1.4 equiv); 
2 
add 32 at -78°C-'O C (79%) (g) 
LiAlH , ether, 0°C-º22°C, lh (85%); TsC1 (1.4 equiv), CH Cl , DMAP 11.1 equiv), Et 1ý (2.5 equiv), 22°C, 4h (i) TsOH 
J(1.1 
equiv), McOH, 16h, 22 C; add NaOCH3 in methanol (80% yield 
of 36). 
OBn 




o Bn OC H2O H3C' 
(41) 
































H 3C 08n 
C02CH3 
X 
(a) Formation of carbanion 40- LDA, (1.1 equiv), THF, -60°C; 
addition oo CS (excess), -6R C-* +5°C, 20min; add CH I (10 
equiv), 32 C, loh, (96%)h (b)+ BuSn8 (1.5 equiv), tolu ne, cat. 
AIBN, 95 C (86%); 1. OM Bu NF In THE (85%); PDC (1.7 equiv), 
CH2C1 , o3A powdered molecular sieves 
(761); (e) preparation of-44 
at -a; 0 CC add anhydrous Ce13 (1 equiv) in THF,. 30min; add 43,. 
-100 C-3 0 C; quench aq. NH C1 (65%); (f) CBr , CH C1 , BaCO (1.7 
equiv), Ph3 P (1.7 equiv), 
445min (75%); (g) tu Snfl (? 1.5 egii3iv) 
toluene, ANN, 65°C, lh, (82%); (h) PPTs (0.5 
ýquiv), McOH, 22°ýC, 
14h (98%); (1) MnO (excess), THF, 5h; then methyl 





Notwithstanding a narrow range of activity constrained 
mainly to Gram positive bacteria, the good activity of the 
pseudomonic acids. against various skin pathogens combined 
with a novel and challenging structure have made them 
inviting targets for total synthesis. There are a large 
number of complete or formal syntheses of-these compounds in 
the literaturell. The conversion of pseudomonic acid C (5) 
to the major metabolite, pseudomonic acid A (1), has also 
1 been reported2. 
Almost exclusively, these synthesis have been directed 
toward the A or C series. Moreover, while some are 
enantioselective, most of these routes rely on sugar 
deriv: 2,. tives as a source of asymmetry. For example, in the 
synthesis of pseudomonic acid C13 the chiral 
tetrahydropyran, bearing 4 contiguous asymmetric centres, 
suggested the use of a reduced carbohydrate precursor. The 
necessary absolute configuration at C-5 is the same as that 
found in the series of L-hexoses. Scheme 1.4 shows how the 
desired absolute stereochemistry at C-5 as well as at C-6 
was introduced at the start of this synthesis from the 
chiral starting material, D-glucosel3b (30). Further 
transformations to allow for attachment of the carbons 11 - 
14 of pseudomonic acid C and subsequent conversion to the 
natural product are shown in scheme 1.5. 
7 
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Scheme 1.7 (cont) 
Pseudomonic acid C 
(5) 
Reagents and conditions: (a) ROH, H 0, then NBS, THE (62%) (b) 
LiBH 
, Et20, then 15% NaOH (100%) (1) tBuPh SiCl (88%) (d) PCC (95%J (e) m-CPBA (f) Et N (74% from 63)-(°q) 
iBuMe SiOTf (90%) (h) 
Dibal (i) Et3SiH, BF . Eit 0, CH Cl , -78 C 
T55% ; verall), (j) 
HOAc, THF, H0 (3: 1: i) ( 5%) , (2k) 
2MeC (OMe ) NMe , xylene (95%) , (1) Os0 (c2t), NMO (90%) (m) CH3000H , 
I-Tos 2OH 
°(90%)-(n) propenylinagnesium bromide, ? tnBr ,1 equii. THF, -78 C (75%); HPLC separation of isomers (o) -BuM 2SiOCH CO2H), D°CC, 0DMAP 
(81%); 
Me SiCl then LDA in situ Me SIC1, 
tHF, 
-780-o, 25 C (55%) 
esterfication (R'-t-Buhe Si) (ý) conversion of methyl ester to 
C-14 metpyl group; Diba12 (80%)- z, PPh (75%) ; Bu SnH, A1BN, 
EtOH, 25 C (70%), (R'- t-Buhe Si (J) proýynyl 1ithiUm, BF3. Et20, 
THF, -78°C (96%) (r) (R)-alplineborane, THF, 25 C (88%) (s) 
PhgH2OCH CO2H, DCC, DMAP (93%b; týen H ,. 10% Pd/BaSO , pyridine, 25 C (BA) (t) LDA, THF, -78 -º25 C; 
then 
Me SiCl (90%); then 
esterification. (R'- Bn). Completion of the s3nthesis, conversion 
to methyl ketone then Horner-Emmons Sondensation 
((MeO) P(O)CH CO(CH ) CO Me, NaH, THF, 25 C (80%) and 













































Another concept. u; a.. lly new approach to the total synthesis 
of pseudomonic acid Cllm, employed the use of a modified 
glycolate ester enolate Claisen rearrangement to introduce 
the required stereochemistry. 
In most of the previous syntheses, the simplifying 
disconnection at the 2,3 and the 10,11 double bonds of 
pseudomonic acid C to give the keto-aldehyde (52) were 
made. Conversion back to the natural product was then 
achieved in a convergent manner by Wittig-Horner or Julia 
coupling (scheme 1.6). 
However, in this synthesis (scheme 1.7), the side chain 
stereochemistry at C-12 and C-13 was related back to the 
chirality around the pyran ring. The use of a silicon 
protecting group on the glycolate carbonyl ester inhibits 
chelation between the ether and carbonyl oxygens. If 
deprotection is performed under strictly kinetic conditions, 
the required threo (anti) ester is formed rather than the 
usual (E) selective deprotonation. This route should also 
be amenable to the preparation of analogues of the 
pseudomonic acids. 
Further work on this route has now been published14. The key 
intermediate, aldehyde (52), has been made from simple 
starting materials and the side chain stereochemistry was 
developed by using the chirality of the central pyran 
fragment. However, the silyl-based glycolate ester enolate 






















From a practical standpoint, a synthesis of non-racemic 
pseudomonic acid C is especially attractive since this 
substance is chemically stable and retains its antibacterial 
activity over a broäd pH range. Whereas pseudomonic acid A 
shows rapid loss of activity outside the range pH 4-9, a 
property associated with intramolecular attack on the 
epoxide by the C-7 hydroxyl substituent, as discussed above. 
In the quest for such a route, the stereoselective total 
15 
synthesis of (-)-monic acid C (79) has been investigated. 
This synthesis has been accomplished in a linear sequence of 
22 steps beginning from dihydropyran and with (-)-l-borneol 
as a chiral auxiliary. This was required since the 
synthesis starts from an achiral starting material 
(dihydropyran) and so an enantioselective step is required 
if optical resolution is to be avoided. 
The synthetic strategy adopted is depicted in scheme 1.8. 
The absolute stereochemistry of the key keto-aldehyde (75) 
is established in this route through an asymmetric 
functionalisation of a dihydropyran (78) using (-)-borneol 
as the chiral auxiliary. The convergence of this key 
intermediate (75) with a five-carbon segment (77) derived 
from ethyl (2S, 3S)-3-hydroxy-2-methylbutanoate , and a 
three-carbon species (76), derived from acetone, sets all 
six chiral centres of monic acid C (79) in place. Scheme 1.9 
shows how this dihydropyran was then elaborated via trans 
epoxides (80,81) to hydroxyselenides (82,83). These were 
then converted to vinyl ethers (84,85) which then underwent 
Claisen rearrangement to give (86,87). Carbosulfenylation 
9 
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Scheme 1.9 (cant) 
Re ents: (a) Br ,CH NMe2, CH Cl2, -780C400C, 6h (b) DBU, 95-C, (c) m-CýloC Iý CSoO3 H, CH C12,48h (d) PhSeSePh, NaBH41 
LiBr, EtOH-THF, 0 
ý96 
C, 3h 
tf) ýH2-CHCOEt, Hg(OCOCF 
reflux, 72h (g) pyrex helices, 250 C, flow rate 0. )6m1, s 
7th) 
AgNO , KOH, EtOH-H 0, o0.5h 
(i) SnC14, CH2C1 , -78 C, 0.5H (j) ýyrex helices, 2185 C (k) Ph CSC1, CH -C(le)OSiMe , ZnBr (cat), CH Cl U 
-methyl 
l. 5h (1) CHý2N , Et20-Et0H, rt3 8h (m)2 
OsO 4 (cat3, 
%r-methyl 
morpholine Iý o2xide, t-BuOH, THF-H 0, 
rt, 72h (n) 1,1-dimethoxycyclohexane, p-TsOH (cat), rt, 
ý. 5h 
(o) (MeO)2POCH CO -tBu, NaH6 LiBr, THF, rt, 17h (p) 
Li(n-Bu)(i-Bu)2 1W, THF, -78 C, 1. '5h (q) PCC, 4A molecular 
sieves, CH2C12. final conversions are as detailed in ref 
15. 
1-01 ( 
+ (-)-1-Borneol --) -ý 
in 
c L' + 
'BOR 
00 OR 
(80) (ai) \a, b, c, d 
Ph e PhSe "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+ 
C. -OH OH 
L0 OR 0y -OR 
(82) e, f (83) 
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OCH=CH2 
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Scheme 1.9 
in the presence of 2-(trimethylsiloxy)propene was 
accompanied by elimination and lead to (88) and its trans 
isomer (89). Cis hydroxylation to (93), protection of the 
resulting diol (93) and Horner-Emmons condensation with 
tert-butyldime thylphosphono-acetate gave (94). Attachment 
of the second side chain of monic acid C was achieved by 
means of Julia olefination with a sulfone prepared from 
ethyl (2S, 3S)-3hydroxy-2-methylbutanoate (95). The 
resulting tetrahydropyran after removal of the three 
protecting 'groups yieded (-)-monic acid C (79). This was 
then converted to pseudomonic acid C (5) 
lla 
and the latter, 
via its methyl ester was further elaborated to pseudomonic 
acid A (1)12. Hence synthesis of monic acid C thus 
constitutes a formal synthesis of these related materials. 
1.3 BIOSYNTHESIS 
The biosynthesis of pseudomonic acid has also been 
studied16. These initial studies have indicated an 
essentially polyketide origin with a number of highly 
unusual features. 
The basic biological precursors were defined by feeding a 
series of radio-isotopically labelled substrates as acetate, 
propionate and methionine. [2-14C]Mevalonic acid lactone 
was not incorporated. This implied that pseudomonic acid 
does not contain an isoprenoid residue deriv: tble from 
mevalonate. 















enriched from C-1 of propionate (*) 





































































































and methionine could be accommodated by the structure of 
pseudomonic acid. The C-17 fragment, monic acid, is' 
composed of a continuous carbon chain extending from C-14 to 
C-1 with 'extra' C-1 units (carbons 15,16 and 17) coming 
potentially from S-adenosylmethionine attached to carbons 
3,8 and, 12' respectively. Two chemical degradations of 
pseudomonic acid derived from D, L-(14C]methionine, indicated 
that C-16 and C-17 were the most likely labelled sites for 
this precursor. - 
To help solve the problem of the difficult chemical 
degradations required to locate the sites of label from 14C 
labelled precursors, 
13C labelled substrates were then used 
in conjunction with high field 
13C 
nmr spectroscopy to 




nmr spectra of 
pseudomonic acid have now been rigorously assigned (see in 
section 2.3)17. However, for these initial studies the 
assignments used were achieved by comparison with spectra of 
the acetonide deriv z. tive, its C-13 ketone analogue and 
8-methoxycarbonyl-octyl-3-methylbut-2-enoate. The 
resonances which could not be unambiguously assigned by this 
method, were distinguished from the incorporation of various 
13C 
acetates. Scheme 1.10 shows the labelling pattern 
deduced from these initial studies. The pathway proposed on 
the basis of these preliminary studies is summarised in 
scheme 1.11. According to this, pseudomonic acid is 
elaborated via C12, C5 and C9 moieties. 
1.3.1 The C9 unit, 9-hydroxynonanoate moiety 
This unit can be considered a priori to be derived 
11 
biosynthetically in a number of ways; 
(a) from a preformed longer fatty acid, such as, oleic acid 
by oxidative degradation, 
(b) from an even numbered carbon chain, such as, decanoic 
acid by a-oxidation, or 
(c) from propionyl-CoA and malonyl-CoA by a process 
similiar to that leading to even numbered carbon chain 
fatty acids. 
However, biosynthetic studies using-13C labelled precursors 
have eliminated these alternatives since the observed sites 
of 
13C 
enrichment and the 
13C-13C 
coupling pattern are not 
consistent with the expected sites. Since, C-1 and'C-9' are 
both derived from C-1 of acetate, the possibility of an 
enzyme-mediated Baeyer-Villiger type oxidation' of 'a 
preformed acetate derived aliphatic chain can also 'be 
discounted. The incorporation of intact acetate units into 
C-8' and C-9'; C-3' and C-4'; C-1' and C-2' (and most 
probably C-5' and C-6') and the incorporation of only the 
carboxyl carbon of a separate acetate unit into C-71-'of the 
9-hydroxynonanoate side chain suggests that the 'primer' for 
its formation may be ß-hydroxy-g-methylglutaryl-CoA 
(HMG-CoA) or a C5 precursor derived from it. The labelling 
pattern of HMG-COA from acetate is well known18 since this 
substance is an important intermediate in the biosynthesis 
of mevalonate, the precursor of the "isoprene" unit in 
terpene biosynthesis. The addition of two malonyl-CoA 
residues to HMG-CoA or a C5 'primer' derived from it are 
required if this is the biosynthetic route to this C9 unit. 
The-terminal carboxyl group would necessarily be reduced and 
12 
theß-methyl group cleaved. 
This theory, does not account for the observed 
13C 
enrichment from [1-13C]propionate solely into C-7' and the 
reduced enrichment of this carbon from [1-13C]- and 
X1,2-13C]acetate 
To explain these observations, the existance of two 
competing pathways for the, formation of this moiety was 
suggested, involving a second 'primer' from a different 
origin. Possibilities for this second 'primer' include 
homo-HMG-CoA or a C5 unit derived from it (possibly the same 
C5 unit derived from HMG-CoA). Some supporting evidence for 
homo-HMG-COA-,. (or the free acid) as an intermediate- in 
metabolic pathways is the incorporation of homomevalonate, 
presumably derived from homo-HMG-CoA, into juvenile 
hormone19 (96). However, Homo-HMG-CoA has never been 
isolated from natural sources. 
These results may have important implications for the 
general biosynthesis of odd numbered carbon chain fatty 
acids. which have been assumed to be synthesised from a 
propionyl-CoA 'primer'. 
1.3.2 The C12 moiety 
This unit comprises of a C10 chain extending from C-5 to 
C-14 of pseudomonic acid, to which two 'extra' carbon atoms, 
C-16 -and , C-17, 
have been attached at C-8 and C-12 
respectively. The alternate labelling sequence from 
[1-13C]- and [2-13C]acetates along this chain -and-its 
formation from five intact acetate units accords with its 
13 
biosynthesis from an acetyl-CoA 'primer' and four 
malonyl-CoA units. In accord with the acetate-malonate 
hypothesis20, the insertion of two 'extra' C1 groups from 
S-adenosylmethionine. would take place at saturated positions 
in the resulting polyketide chain. The functionalities 
present in this moiety, in the final metabolite, arise via 
oxidative and reductive modifications. Mellows et al 
proposed that the pyran ring was probably generated by 
eliminating water from an open-chain diol intermediate. 
1.3.3 The C5 moiety 
Incorporation results from 
13C labelled acetates indicate 
this unit could be derived via HMG-CoA. It is known21 that 
in rat liver HMG-CoA can undergo enzymic decarboxylation, 
producing hydroxyvaleryl-CoA, which can then undergo 
dehydration to produce dimethylacryloyl-CoA. The latter 
molecules have been shown to have the same labelling 
patterns from acetate as the C5 moiety of methyl 
pseudomonate, ie. carbons 2,4 and 15 derived from C-2 of 
acetate; carbons 1 and 3 from C-1 of acetate and two intact 
acetate units forming carbons 1,2 and carbons 3,4. However, 
3-methylbut-l-enyl CoA which could be formed by 
isomerisation of dimethylacryloyl-CoA may be a more 
appropiate condensing unit. 
1.4 CONCLUSIONS 
Amongst the unusual features of this proposed pathway are: 
(i) The possible involvement of 
14 
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Myxovirescin (100) 
ß-hydroxy-ß-methylglutarate in the formation of both 
the C9 and the C5 moieties, 
(ii) the derivation of C-7' from the carboxyl carbon of 
both acetate and propionate, 
(iii) the origin of the C-15 methyl from the methyl of a 
cleaved acetate unit. 
This feature has been observed more recently in the 
biosynthesis of the virginiamycins22 (97,98, and 99), 
myxovirescin23 (100), the myxopyronines24 (12 and 13) and 
the aurantinins6 (10 and 11) but no satisfactory 




Biosynthesis of Pseudomonic Acid 
FIGURE 2.1 
HPLC trace of a standard sample of pseudomonic acid obtained 
using a Waters p-bondapak C-18 column, eluting at a flow 
rate of 1.5ml/min of methanol/0.05M ammonium acetate (3: 2, 
v/v), pH4.5, uv detection at 230nm. 
A 
590p1 Pseudomonic acid 
0.2 OD 10p1 sample 
A=Pseudomonic Acid A 





Biosynthesis of Pseudomonic Acid 
2. INTRODUCTION 
As discussed in chapter 1, Pseudomonas fluorescens (soil 
isolate, NCIB 10586), when grown in submerged culture 
produces the group of novel antibiotics collectively known 
as the pseudomonic acids. Extraction of the culture 
filtrates, followed by purification, provided materials 
containing over 90% pseudomonic acid A (1) and ca. 5% 
pseudomonic acid B (4) and minor amounts of pseudomonic 
acids C (5) and D (6). In the present work, two different 
fermentation media were investigated. Fermentation medium 1 
was that used by previous workers16 and fermentation medium 
2 was that supplied by workers at Beecham25, and was a 
modification of another published work4. Production of 
pseudomonic acid in these two media were compared. Analysis 
was by hplc. Figure 2.1 shows a typical trace for analysis 
of a standard sample of pseudomonic acid. Fermentation 
medium 2 produced the best yields and so was used in all 
subsequent experiments. 
2.1 GROWTH PRODUCTION STUDY 
For biosynthetic studies, it is necessary to determine the 
period of metabolite production, and this was achieved by 
carrying out a growth production study. Production of the 
pseudomonic acids involves a two stage fermentation. The 
bacterial culture is maintained on agar slopes at 4°C, and 
stage one involves transfering some bacterial cells from the 
16 
TABLE 2.1 
Production of pseudomonic acid with time., 
TIME AFTER INOCULATION pg/ml PSEUDOMONIC ACID A 
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storage slope into the 
is used to obtain good 
this liquid culture is 
(production) stage liq 
required constituents 
metabolites. 
primary stage liquid culture. This 
bacterial cell growth. A sample of 
then used to inoculate the second 
uid medium which contains all the 
for good production of the 
The preliminary growth production study used ten 250ml 
Erlenme>jef flasks, each containing 25m1 of second stage 
medium. At timed intervals, O. lml of culture fluid was 
removed from all ten flasks, combined and after 
micro-filtration was analysed by hplc against a standard 
sample of pseudomonic acid of known concentration. The 
results are summarised in table 2.1 and figure 2.2. Several 
repetitions of this preliminary growth production study 
indicated that intial production of the metabolites occurred 
at approximately 20h and reached a maximum after 60h. 
Another pre-requiste for ensuing biosynthetic studies was to 
determine the time for feeding labelled precursors to the 
second stage medium for maximum incorporation and good 
production of the metabolite. This information can be found 
from an incorporation experiment using [1_14 Clacetate and 
the specific activity of the pseudomonic acid isolated was 
assessed by liquid scintillation counting. The results, 
which are summarised in table 2.2, indicated that for good 
production and incorporation of label, labelled substrates 
should be added to the second stage medium after 20h 
growth. From earlier work16, there are twelve labelled sites 
from acetate, hence the dilution per labelled site is equal 
17 
TABLE 2.2 
Specific activities and dilutions per labelled site for methyl 
pseudomonate after incorporation of [1-14C]acetate. 
FERMENTATION TIME YIELD SPECIFIC ACTIVITY DILUTION PER 
LABELLED SITE 
(h) (mg) (dpm/mmol) 
10 30 6.44X104 848, 
15 20 2.40x105 22.7 
20 15 1.94x106 0.28 
CONTROL 
. 50 ----ý ý--" 
to the specific activity times the number of labelled sites, 
giving the dilution values quoted in table 2.2. This meant 
that 3C enrichment of about 10.8% could be expected if 90% 
1 
enriched 
13C labelled acetates were fed to the culture under 
these experimental conditions. Again, repetition of this 
experiment verified these findings. 
2.2 USE OF NMR IN BIOSYNTHETIC STUDIES 
Apart from intial incorporation experiments, where 
radio-labelled precursors were used, substrates labelled 




were used in further 
studies. The sites of labelling were determined by nmr 
methods. The use of stable isotopes together with high 
field nmr has solved the' problem of location of labelled 
sites in, isolated metabolites. The use of radio-isotopes 
necessitates extensive degradative chemistry to locate the 
position of incorporated isotopic label. This degradative 
chemistry usually requires experimentally demanding and 
often impractical chemistry, especially where the metabolite 
has been labelled from a simple precursor such as acetate or 
mevalonate and is labelled in many sites. However, if 
accurate quantitative data on incorporation of labelled 
atoms into a metabolite is required, but the precise 
location of the label is not important, the use of 
radio-isotopes easily serves this purpose. This is the 
method of choice for establishing the most efficient 
precursor feeding regime prior to 
13C labelling studies. The 
precursor efficiency can be assessed by calculating the 
1 dilution of added label. For 4C, dilution 26 per labelled 
18 
site is given by: 
specific activity of precursor x number of labelled sites 
specs is activity o product 
The most important stable isotopes in biosynthetic studies 
are 
13C, 2H, 180 
and 
15N. 13C 
enables the biosynthetic 
origins of the carbon atoms in a molecule to be elucidated. 
The biosynthetic origins of the hydrogens and oxygens can be 
determined by use of 
2H 
and 
180. With singly isotopically 
labelled substrates, mass spectrometry and 
2H 
nmr can be 






13C (used as a 'reporter' nucleus) then the 
labelled sites can be determined by observation of isotope 
induced shifts in the high field 
13C 
nmr of the isolated 
metabolite. The applications of stable isotopes and high 
field nmr to biosynthetic studies has been well reviewed by 
26 





nmr provides a non-destructive detection 
system which can be used to determine the location and 
relative concentration of each chemically non-equivalent 
carbon in a molecule. It also, enables the presence of 
2H 
and 
180 to be demonstrated by use of isotope induced shifts 
in the 13C resonance frequencies (or coupling) to 
13C. 
Since 
180 has a nuclear spin (I) equal to 0 it must be 
detected by indirect methods. However, 
2H has I-1, and so 
it can be detected directly but with nuclei of i-1, 
quadrupolar relaxation is observed and so the signals are 
broad. But, rapid relaxation and lack of any nOe-means that 
accurate integration of 
2H 
nmr spectra is possible so that 
19 
FIGURE 2.3 
A contour plot of the 250 MHz 2D 
1H SECSY(45°, N-type) spectrum of 
pseudomonic acid A in CD OD. Connectivities between 
scalar-coupled protons are indicated by the bold diagonal lines 
linking the relevant cross-peaks. The cross-peak marked with a 
triangle (A) is due to H-9a, 9b and that mjarked with a circle (") is 
due to H-4, H-7'. The "conventional 1D H nmr spectrum is shown 
above the 2D spectrum. 
HOD 
4ox , is 6; s; 6; 
` 
7; 12 17 
f 













Sý 0 2,: 
M00 160x7 S 
4e ß 3: 8,12 
16eQ 6 4ax 
ý 
31 






i 4 eQ 













12 (D. p m. ) 
the relative enrichment at different sites in the metabolite 
can be assessed. Also, its low natural abundance (0.012%) 
means that much greater dilutions are tolerable, compared to 
13C (natural abundance 1.11%) which requires very efficient 
incorporation of the precursor into the metabolite. This 
makes 
2H-labelling 
attractive for the study of advanced 
intermediates in biosynthetic pathways. The inherent lack 
of resolution in 
2H 
nmr can be overcome by the use of 
isotope induced shifts in 
13C 
nmr. When deuterium is 
substituted either a or $ to a 
13C, then this causes a 
change (usually upfield) in the 
13C 
chemical shift. 
Similarly, the presence of 
180 
a to a 
13C 
atom can be 







NMR ASSIGNMENT OF PSEUDOMONIC ACID 
0 




nmr of a natural 
product-is usually a pre-requisite for ensuing biosynthetic 
experiments in which stable isotopes are used. In the case 
of pseudomonic acid A, complete 
1H 
nmr spectral assignments 
were determined by Everett and Tyler17 using a two 
dimensional (2D) chemical shift-correlated SECSY 1H nmr. 
Figure 2.3 shows a contour plot of a (SECSY)1H nmr spectrum 
of pseudomonic acid in CD30D. 
In a SECSY spectrum, connectivities between scalar-coupled 
protons are detected by the presence of symmetrical 
cross-peaks in the fl dimension of the 2D spectrum. These 
cross-peaks occur at half the chemical shift distance 






















































adjacent protons in -- the structure. Starting from the 
olefinic proton H-2, which may be unambiguously assigned to 
the signal at; 65.73, connectivities -can be seen to both 
4-protons and the, C-15 methyl. Further connectivities may 
then be traced in an unbroken sequence all the way across, 
the ring and down the-epoxide side chain to the C-14 methyl. 
In the nonanoic - side chain, connectivities are-seen from 
C-9' to C-8' to C-7', and from C-2' to C-3' to C-4'. - Thus 
the only, protons whose -chemical shifts cannot be 
unambiguously assigned are the C-5' and C-6' protons- in- the 
middle o£, this nonanoic acid:; side: chain,. - 
The assignment of the 
13C 
nmr17 spectrum of pseudomonic-acid 
A was achieved by a 2D 
13C, 1H-correlation 
spectrum, shown 
in figure, 2.4. This type. -of 2D spectrum, correlates the. 
chemical shift of -a proton with the -chemicals shift of the 
carbon to which it is directly bonded. For example, the 
chemical shift for the protons of the C-17 methyl occurs at 
60.94 An , 
the 1H- nmr spectrum and in the 2D. 
1H, 13C 
correlation spectrum a cross-peak is seen at 6H0.94, SC 12.4. 
Hence, 
-this 
unambiguously assigns the-13C, resonance of the 
C-17;: methyl at-&C12.4. 
2.4 PRODUCTION OF THE PSEUDOMONIC ACIDS 
In intial work, production of the metabolite was erratic. 
Reliable production was achieved for only a short time 
during which a number of experiments were carried out. 
Incorporationý", of -[1-14C]acetate, 11_13C, 1802]acetate, 
[1- 13C, 2H3]acetate, [3-14C]-ß-hydroxy-ß-methylglutarate, 
21 
1602 
uptake measurements and finally 
1802 
experiments were 
carried out before yields of the metabolite became 
unacceptably low, and these experiments are discussed below. 
After consultation with workers at Beecham25, the problem of 
poor production was traced back to subculturing of P. 
fluorescens. - Intially the culture was maintained on 
nutrient agar slopes at +4°C and subcultured every 2 months. 
In subculturing, a loopful of bacteria from an original 
slope is transferred to a new slope which is then incubated 
at 25°C for 48h, so producing slopes with fresh cell growth. 
As with all living organisms, the original cells age and die 
and so by producing fresh cell growth the culture is 
maintained in a viable condition. However, on subculturing, 
vegetative growth, of the bacterium remained unaffected but 
production of the metabolite decreased after each 
subculture. A set of working slopes - maintained on 
nutrient deficient agar slopes25 - from a freeze-dried 
isolate were then set up and used to inoculate the second 
stage flasks. By using these nutrient deficient agar 
slopes, any active growth of the bacterium on the slopes is 
slowed down and so consequently the cells remain viable 
longer. Titres of the metabolites were also increased by 
using 'spiked' or 'baffled' flasks, in the second stage, of 
the fermentation, which improve the degree of aeration of 
the medium as it is shaken on the rotary incubator by 
disrupting the circular motion of the liquid. 
Another growth production study was carried out, again ten 
second stage flasks were used. This time 250ml 'baffled' 
22 
TABLE 2.3 
Production of pseudomonic acid with time. 
TIME AFTER pH pg/ml PSEUDOMONIC ACID A IN 
ErIOCULATION (h) CULTURE FILTRATE 
8 6.7 0 
17 5.8 45 
20 5.2 139 
24 5.2 220 
28 5.1 290 
32 5.0 354 
47 8.3 523 
FIGURE 2.5 

























flasks were used, O. lml was removed from each flask and 
combined, but this time the pH of this extract was adjusted 
to 8 and the cells removed by centrifugation. The pH change 
is required because at low pH pseudomonic acid is bound to 
protein and so the intial production is not detected if the 
pH is unadjusted. During the fermentation, the pH drops to 
approximately 4.5 as the glucose is used up by the bacteria 
and then the pH rises as the fermentation continues to end 
at approximately 8.0. The results of this study are shown 
in figure 2.5 and table 2.3. Incorporation studies which 
investigated the role of; 
(3,6-13C2]0-hydroxy-ß-methyl-glutarate, malonate, 
bicarbonate and advanced precursor studies and the related 
'check' feeds (chapter 3) were all performed using these 
modified culture and fermentation conditions. 
23 
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Results and Discussion 
The incorporation of a variety of precursors labelled with 
stable isotopes has been studied in order to provide more 
detailed information on the exact nature of the 
intermediates involved in the formation of pseudomonic acid. 





ATMOSPHERE OF 02, AND [1-C, 
2H3]ACETATES 
There are a number of biogenetically reasonable mechanisms 
which can be proposed for the formation of the 
tetrahydropyran moiety depending on the structure of the 
intermediate produced by the chain assembly enzymes. Some 
of these are summarised in scheme 2.1, and they can be 
distinguished by determination of the biosynthetic origins 
of the hydrogen and and oxygen atoms. 
In mechanism (a) the first step is dehydrogenation to 
generate an aß-unsaturate rd ketone (102) which is then 
attacked by the hydroxyl group on C-5 in a 'Michael' type 
cyclisation to generate the intermediate pyran ring (103). 
This pyran ring is further modified by reduction of the 
ketone group on C-7 to a hydroxyl group and oxidation at C-6 
to introduce another hydroxyl group at this position. A 
second possibility is illustrated by route (b). The first 
step is dehydration between C-5 and C-6 to generate another 
aß-unsaturated ketone (106), which is then epoxised. The 
24 
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nmr spectrum of methyl pseudomonate labelled by 
(1-13C, 1802]acetate. 
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180 isotope-induced shifts observed in the 90.56 MHz 
nmr spectrum of pseudomonic acid. 
CARBON SC (ppm) ASx100 (ppm)a ASx100 (ppm)b 
1 166.7 3.7 
3 156.5 5.1 
5 74.7 1.7 5.5 
13 71.3 2.3 4.9,9.1,13.7 
7 70.3 2.3 
9' 63.7 2.9 2.9 
11 61.2 7.2 
9 31.5 13.7 
5' 29.0 10.1 




b (1-13 C, 2H3]acetate enriched. 
I 
methyl group on C-8 is hydroxylated and this introduced 
hydroxyl group attacks the epoxide to generate the pyran 
ring (107). The ketone on C-7 is reduced to a hydroxyl 
group, so producing the required tetrahydropyran ring with 
the substitution pattern found in pseudomonic acid. A third 
possibility, which is a variation on the second. mechanism, 
is shown as route (c). Again the first step is dehydration 
followed by epoxidation to generate the intermediate (106). 
This time, the epoxide is hydrolysed to form the diol (109) 
which is cyclised via an activated phosphate to generate a 
pyran ring. The final modification is again reduction of 
the ketone group on C-7 to a hydroxyl group. This open-chain 
diol (109) was proposed by the original workers as being the 
most probable biosynthetic intermediate to the pyran ring. . 
Incorporation of (1-13C, 
1802]acetate 
and fermentation in an 
1802 
enriched atmosphere will enable the origin of all the 
oxygen atoms to be elucidated by observation of isotope 
induced shifts in the 
13C 
nmr spectra of the enriched 
metabolites. Incorporation of [1_13C, 
2 H3]acetate and 
analysis by 
13C 
nmr will enable the biosynthetic origins of 
the hydrogen atoms to be determined. 
Sodium [1- 
13C, 1802]acetate 
was successfully incorporated 
into pseudomonic acid. The sites of labelling in the 
enriched metabolite were determined by observation of 
isotope induced shifts in the 13C nmr spectrum. The isotopic 
substitution with 
180 induces an upfield shift in the 
position of the nmr resonances of a directly attached 
13C 





Apparatus for the growth of cultures in an 
1802 
atmosphere. 
The wash bottles are arranged so that the first acts as a 
suck-back trap, the second contains 5M KOH to absorb CO2 
produced by the cultures and the third contains cotton wool 
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of oxygen uptake by P. fluorescens versus 
0 10 20 30 40 SO 60 70 80 
Time (h) 
4 
(figure 2.6) of this enriched metabolite showed five shifted 
signals and these are detailed in table 2.4. Hence, the 
oxygen atoms attached to C-1, C-5, C-7, C-13 and C-9' 
(indicated in scheme 2.2) are all derived from acetate. 
In an attempt to ascertain the origins of the remaining four 
oxygen atoms present in pseudomonic acid (le. the epoxide, 
C-4 hydroxyl and the carboxylic acid oxygen atoms), P. 
fluorescens was grown in an atmosphere of 
1802 
gas, using 
the apparatus, shown in figure 2.7, which allows the oxygen 
pressure to be kept constant and the oxygen uptake to be 
monitored. Due to the expensive nature of 
1802 
gas, an 
intial experiment using 
1602 
was carried out to measure the 
oxygen uptake during fermentation of the culture. This. also 
served to check that growing the culture in this unnatural 
atmosphere, ie. where the CO2 produced is constantly removed 
from the system, had no adverse affect on the production of 
the metabolite. This is indeed the case. Figure 2.8 and 
table 2.5 relates oxygen uptake by the culture to 
fermentation time. These show that, the maximum uptake of 
oxygen occurs from 24h and has passed its maximum level by 
45h. Hence, for the most economical use of 
1802 
gas, the 
culture was grown for 24h, which is the intial growth phase 
of the bacterium, before being attached to the closed 
180 
apparatus for the period of metabolite production. In the 
intial 1602 uptake study, the fermentation was continued for 
72h, the time required for maximum metabolite production. 
However, since the oxygen uptake by the culture has passed' 
its maximum level by 45h, the fermentation in the closed 
system using 
1802 





uptake with fermentation time. 
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P. fluorescens versus time. 
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nmr spectrum of methyl pseudomonate labelled by 
(1-13C, 2H3]acetate. 
Table 2.6 and figure 2.9 illustrate the 
1802 
utilization 
with fermentation time. However, in this experiment, 
production of the metabolite was poor and only 8mg of a 
white solid was isolated from this experiment. The 
13C 
nmr 
spectrum of this isolated material was obtained but the 
sample was so weak, that apart from proving that the sample 
was indeed methyl pseudomonate, observation of any a shifts 
induced by incorporation of 
180 
was not possible. To try 
and determine if any 
180 had been incorporated, high 
resolution mass spectrometry was tried. Unfortunately, due 
to problems obtaining this analysis, no information about 




was also sucessfully incorporated 
into pseudomonic acid, and the resulting enriched metabolite 
was analyse!. c by high field 
13C 
nmr. A number of 
isotopically shifted signals, corresponding to ß shifts (2 
bond) were observed in this spectrum (figure 2.10, table 
2.4). These upfield shifts in the positions of the 
13C 
resonances are due to the incorporation of 
2H 
on the carbon 
atom two bonds away from the carbon showing the shifted 
signal(s). There are three shifted signals at C-13, 
corresponding to the incorporation of up to three deuteriums 
on c-14 indicating that this is part of an acetate chain 
'starter' unit. There are also singly shifted signals for 
the incorporation of a single 
2H, from acetate, on C-4, C-6, 
C-10, C-12, C-8', C-6' and C-4'. Interestingly, there is no 
observed shifted signal for C-7, indicating that no 
2H 
was 
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Scheme 2.3 
incorporated 2H in the isolated enriched metabolite. 
From the (1-13C, 
1802]acetate incorporation experiment, five 
oxygen atoms came from acetate, ie. the oxygen atoms at C-1', 
C-5, C-7, C-13 and C-9', and this result can be used to 
distinguish between the possible mechanisms for the 
formation of the tetrahydropyran ring. 
Therefore from the knowledge of the origins of the oxygen 
atoms, only mechanism (a) in scheme 2.1 is consistent with 
the observed labelling pattern. Routes (b) and (c), by 
first dehydrating between C-5 and C-6, lose the oxygen atom 
at C-5 which is acetate derived. This is actually 
maintained in the final metabolite, as shown by an a shift 
observed in the 
13C 
nmr spectrum at the C-5 resonance. 
Indirect supporting evidence for route (a) being the 
mechanism for the formation of the pyran ring comes from the 
observed 
2H labelling pattern from. (1-13C, 
2H3]acetate. No 0 
shift was observed at the C-7 resonance in the 
13C 
nmr 
spectrum of the enriched metabolite, and this indicates that 
the 2H which comes from acetate has been lost in the 
biosynthetic transformations to pseudomonic acid. This is 
consistent with route (a) since the first step in this 
mechanism is dehydrogenation between C-8 and C-16 with the 
loss of 
2H from acetate. In all the other routes (b) and 
(c), the 
2H from acetate would be maintained in the final 
metabolite which is inconsistent with the observed labelling 
pattern. 
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r 
incorporation also establishes that both oxygen atoms 
involved in the unsaturated ester link between monic acid 
and 9-hydroxynonanoic acid are acetate derived. This 
confirms earlier findings by Mellows and co-workers16 that 
pseudomonic acid is not derived via, for example, a 
Baeyer-Villiger type cleavage of a single long chain ketone 
intermediate but from separate C17 and C9 moieties. Scheme 
2.4 illustrates this point. 
2.6 SYNTHESIS AND INCORPORATION OF [3-14C]- AND 
[3,6-C2]-9-HYDRORY-ß-METHYLGLUTARATE 
13 
Intial biosynthetic studies by Mellows and co-workers16 
implicated ß-hydroxy-6-methylglutarate in the biosynthetic 
pathway to pseudomonic acid (scheme 1.11). This proposed 
involvement of ß-hydroxy-ß-methyl-glutarate (HMG) in the 
formation of the C9 and CS/C17 moieties by providing. C-3, 




13C labelled forms and 
subsequent feeding studies. 
The synthetic route0to this precursor has been modified from 
a previous synthesis of mevalonic acid29. Due to the 
expensive nature of 
14C 
and 
13C labelled starting materials, 
all syntheses- were first carried out using unlabelled 
starting materials in order to optimise reaction conditions. 
Scheme 2.5 details this synthesis. Step 1, involves the 
conversion of labelled sodium acetate (112) into labelled 
nbutyl acetate (113) in a transesterification reaction with 
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Di-sodium salt 24 
Di-ethyl ester 20 
incorporation studies using 
lutarate. 




with allyl bromide in a Grignard reaction to generate 
4-hydroxy-4-methyl-hepta-1,6-diene (114) which in turn was 
converted to the diacid (115) by ozonolysis at -78°C, 
followed by oxidative workup. For incorporation studies, 
both these labelled forms, le. 
14C 
and doubly labelled 
13C, 
of glutarate were converted to the di-sodium salt. The 
14C 
labelled glutarate was also converted to the corresponding 
diethyl ester. All the compounds were analysed by 
1H 
nmr 
spectroscopy and were found to be identical to authentic 
spectra. The fully proton coupled 
13C 
nmr spectrum of 
[2,3-13C]-ß-hydroxy-ß-methyl glutarate was obtained and is 
shown in figure 2.11 and illustrates the couplings between 
the labelled carbons and directly attached and remote 
hydrogens. 
In order to determine the optimum feeding conditions for the 
13C labelled glutarate, the 
14C labelled glutarate was fed 
to the growing second stage culture in two separate 
experiments, as its. di-sodium salt (250mg, 1.2mmol) and as 
its diethyl ester (250mg, 1.15mmol). The isolated enriched 
metabolites was analysed by tic against a standard sample of 
methyl pseudomonate and the specific activity of the 
isolated methyl pseudomonate was then determined by liquid 
scintillation counting. The results from these two 
incorporation experiments (table 2.7) show that this 
14C 
labelled HMG was incorporated with higher efficiency into 
pseudomonic acid as the di-sodium salt. To locate the 
actual sites of labelling the [2,3-13C2]HMG was fed as the 




























































enrichment observed in the 100.61MHz 
13C 
nmr spectrum of 
methyl pseudomonate enriched from 









1 167.99 77 14 20.94 39.8 
2 118.39 77 15 19.22 
3 157.69 41.6 16 65.83- 
4 43.17 41.4 17 12.80 
5 75.37 42.3 1' 175.79 58.7 
6 69.44 42.4 2' 34.33 58.5 
7 70.81 36.7 3' 25.08 35.8 
8 39.79 36.6 4' 
9 31.84 45.4 5' 29.27 signals 
10 55.95 45.3 6' overlap 
11 61.71 44.3 7' 26.13 
12 43.10 44.2 8' 28.88 39.1 
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An intial incorporation experiment with the doubly 
13C- 
I 
labelled di-sodium HMG was preformed using the intial set of 
fermentation and subculturing conditions. The yield of'the 
isolated, enriched - metabolite was poor - 10mg as a 
colourless oil, and-the 
13C 
nmr spectrum showed 
13C_13C 
coupling satellites throughout. This indicated that the 
precursor had not, been incorporated intact, but had, been - 
taken up by-the cells and degraded to acetyl CoA-and 
subsequently incorporated into the final metabolite. There 
was no evidence for enhanced enrichment at C-3, C-4 and 
C-7', the expected sites of labelling had the precursor-been 
incorporated intact. -This experiment was repeated after the 
problems with the fermentation and metabolite production had 
been resolved. Using the modified fermentation conditions, 
di-sodium [2,3-13C2]HMG was fed to a growing second stage 
culture. This time-the production of- the metabolite was 
good (43mg). and the 
13C 
-nmr spectrum (figure 2.12) again 
showed , 
13C_13C 
coupling satelites throughout the molecule 
and these are summarised in table 2.8. The level of 
13C 
enrichment was much better than that achieved intially,, but' 
there was still no evidence for preferential enrichment of 
C-3, C-4 and C-7', required by the previously: proposed 
pathway, (scheme 1.11). Hence, the observed incorporation 
of label from ß-hydroxy-ß-methyl glutarate into pseudomonic 
acid is entirely via prior breakdown to, acetyl CoA and 
subsequent re-incorporation (scheme 2.6), and so HMG does. 
not appear to be directly involved in pseudomonic acid 
biosynthesis. 
Recently, other workers32a, 
b have -discussed results using 
31 
14C labelled HMG which they interpret in` favour of intact 
incorporation. However, they do not actually locate 'the 
actual labelled sites in" the Isolated'-enriched metabolite. 
These workers, Mantle et al 
32a 
, in their' incorporation' 
studies, used the fermentation conditions detailed in the 
original paper16 on pseudomonic acid biosynthesis. Their 
evidence for intact incorporation of glutarate was based on 
percentage incorporation of 
14C label into pseudomonic acid 
from [3-14C]-ß-hydroxy-ß-methyl glütarate (HMG). They found 
a 0.9% incorporation of'HMG'and compared this value-to that 
obtained from an incorporation study using (1=14Cjacetate. 
HMG incorporation was approximately twice that found for 
[1-14C]acetate'which suggests that'HMG is a more specific 
precursor than acetate which provides most"of" the carbon 
atoms in pseudomonic' acid. In further studies32b,, 
[3-14C]HMG was fed to a P. fluorescens culture to` which 
ethionine had been added. Ethionine serves " to inhibit 
pseudomonic'acid biosynthesis' and causes monic acid A tobe 
produced. Interestingly, ' this isolated monic acid A was not 
significantly-labelled with 
14C. This finding was explained 
by' ' suggesting ' that' this' monic acid represents late 
synthesised compound constructed from late' synthesised 
precursors` which are excess to biosynthetic 'demand as 
pseudomonic acid biosynthesis ceases' at the' end of 
fermentation. ' If this monic acid A had been' a degradative 
product from pseudomonic -acid, then it should have shown n-a 
similar specific radioactivity after adminstration 'of' 
[14C]HMG - as-described previously. The 
14C label from' 
[14C]HMG fed in this experiment was accounted for in the 
folllowing manner; 'a small amount 7.6 - 7.7% was located'in 
32 
the broth, and the remainder was assumed to have been 
largely cell associated or lost as 
14CO2 during the 
fermentation. This finding detracts rather than 
substantiates the earlier conclusion found by these workers. 
2.7 SYNTHESIS AND INCORPORATION OF [2-13C]MALONATE- 
In order to obtain more information on the biosynthetic 
origns of these carbon atoms which had been predicted to be 
derived from HMG, le. C-3, C-4 and C-7' in pseudomonic acid, 
the role of malonate in this biosynthetic pathway was 
investigated. Malonyl-CoA derived from carboxylation of 
acetyl-Co A is the basic chain extension unit in both fatty 
acid and polyketide biosynthesis. Incorporation of 
[2_13C]malonate and observation of differential levels of 
labelling could provide information on "starter" groups and 
chain extension processes. Previous workers, 
Mellows et al 
16, did not investigate the role of malonate 
in this pathway but found that the idea of propionyl-CoA as 
the 'primer' and chain extension by three malonate units did 
not fit the observed labelling from (1_13C]_, (2-13C]- and 
[1,2-13C]acetates. By this theory, C-9' would necessarily 
have to be derived from C-2 'of acetate and not from C-1 as 
found, and the chain extension does not fit simple acetate 
plus malonate additions since there is a change in direction 
of addition of the acetate units between C-9' and C-8'. 
Also, the level of enrichment at C-7' is significantly less 
than that observed elsewhere in the enriched metabolite. 
The anomaly of label from (1-13Cjpropionate going solely 
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They proposed that the 'primer' for this C9 moiety might be 
ß-hydroxy-ß-methylglutarate, a theory for which no 
supporting evidence has been found in the present work. 
Diethyl (2-13C]malonate was synthesised33 as shown in scheme 
2.7. As with the synthesis of the labelled HMG precursors, 
the synthetic route was first optimised using unlabelled 
materials. This synthesis again starts from [2-13Cjacetate 
which is converted to ethyl [2-13C]acetate (118) by an ester 
exchange reaction with triethyl phosphate31. Lithium 
di-isopropylamide (LDA) was then used to generate the 
enolate of the labelled ethyl acetate, which was then 
condensed with ethyl chloroformate at -78°C, so generating 
the labelled diethyl malonate (119). Again, all 
intermediate compounds in this synthetic route were 
analys. 4ea - by 
1H 
nmr spectroscopy. All were identical to 
spectra obtained from authentic material. The 
1H 
nmr 
spectrum of diethyl (2-13Cjmalonate also indicates the 
degree of 
13C labelling. Since, 90 atom % sodium 
(1-13C]acetate was used in this synthesis there was a small 
residual signal for 
12CH2 
at 62.0 andamuch more intense 
doublet due to 
13C 
coupling to 
1H for 13CH2. For 
incorporation studies di-sodium malonate was also 
synthesised, by base hydrolysis of diethyl malonate. The 
authenticity of this labelled malonate was checked by infra 
red spectroscopy. The infra red spectrum showed bands for 
carboxylate ions rather than ester carbonyl stretching 
bands, indicating that the ester groups had been hydrolysed. 
The high field 
1H 
nmr spectroscopy showed no ester signals 




enrichment observed in the 
13C 
nmr spectrum of methyl 
pseudomonate 





2 117.8 2.0 3.0 
4 44.0 1.9 2.1 
6 74.2 1.9 2.6 
8 35.1 1.9 2.8 
10 55.5 2.0 3.1 
12 42.8 1.9 2.1 
14 20.6 1.8 2.4 
15 18.9 2.0 2.9 
2' 34.0 2.3 3.5 
4' 29.0 2.0 3.8 
6' 29.0 2.0 3.8 
8' 28.7 2.1 3.9 
a 250mg [2-13C]malonate (100.61MHz 
13C 
nmr spectrum) 
b 1.07g [2-13C]malonate ( 75.47MHz 13C nmr spectrum) 
90%. 
Using the modified fermentation conditions, as detailed 
previously, diethyl (2-13C]malonate (250mg, 1.6mmol) was fed 
to a growing second stage culture after 20hrs fermentation. 
Production of the metabolite was good (50.5mg), and this was 







nmr spectrum was compared with a natural 
abundance 
13C 
nmr spectrum determined under exactly the same 
experimental conditions as used for the enriched sample, 
there was no observed enrichment at all. One possible reason 
for this lack of observable incorporation could be a 
transport problem since P. fluorescens is a Gram negätive 
bacterium, and consequently transport problems across the 
cell wall and membranes, to the site of synthesis inside the 
cells, must be considered. To try to solve this possible 
transport problem, the [2-13Cjmalonate was re-fed as the 
di-sodium salt, allowing for the possibility of the malonate 
in this charged form, being able to enter the cells via the 
charged pores through which salts normally pass into the 
cells. The modified culture and fermentation conditions (as 
described previously) were used in this incorporation study. 
Again, production of the metabolite was reasonable, and the 
high field 13C nmr spectrum of this isolated metabolite was 
determined and this time it did show observable 
incorporation of 
13C label into the metabolite. The levels 
of enrichment at the various sites in the isolated methyl 
pseudomonate are detailed in table 2.9. These were 
calculated by comparing the intensities of the lines in the 
natural abundance 
13C 
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observed in the 
13C 
nmr spectrum of the enriched sample, all 
these spectra were obtained under the same experimental 
conditions, and these enrichment levels were then normalised 
with the average intensity' of all the known un-enriched 
signals. This method for quantifying 
13C 
enrichment is not 
necessarily the best and the problems associated with trying 
13 26 to quantify C enrichment are well reviewed by Simpson. 
Scheme 2.8 illustrates the observed enrichment levels, and 
from these, all sites labelled from the methyl carbon from 
acetate were also labelled equally from malonate. There was 
no significant enrichment at any site indicating "starter" 
unit effects. This experiment was repeated, but this time 
the precursor was fed at a much higher level, to see if 
differential incorporation could be observed; 1.07g 
(7.2mmol) of malonate was fed as a solution in sterile water 
to 125ml of a growing second stage culture, compared to 
1.7mmol of malonate to 250m1 of second stage culture, used 
previously. Methyl pseudomonate (30mg) was isolated from 





spectrum obtained is shown in figure 2.13 and evidence for 
differential incorporation was obtained. The 
13C 
enrichment 
levels were calculated from line averaged intenties from two 
1 
sets of acquired data, le. the. 
3C 
nmr spectra of the 
natural abundance and enriched sample were obtained twice. 
This was done to compensate for the random variation in 
intensities in the spectral lines, even although the spectra 
were obtained from the same sample, under the same 
experimental parameters. The 
13C 
enrichment was then 
calculated by dividing the average line intensity of the 
enriched sample by that of the natural abundance and then 
36 
jC02H 





Scrambling of label (2) 
C02H "C02H 'COSCoA 
CH (0] 
aCH -ý aCH 
ii ---ý ,21 
CH3 CH2OH CH20H 
(122) (123) 
Scheme 2.9 
--+ -p -º 
normalising it with the average spectral line intensity from 
all non enriched signals. This ensures'more reliable 
13C 
enrichment values, which are detailed in'table 2.9. The 
13C 
enrichments levels are much higher 'in the 9-hydroxynonanoic 
acid side chain compared to the levels observed in the monic 
acid portion of pseudomonic acid, and these results are, 
summarised in scheme'2.8. 
E ý: 
From these observed enrichment levels,, malonate does'-appear 
to play an important role in the biosynthesis of the 
9-hydroxynonanoic acid moiety. Four intact acetate'units 
appear to form this moiety, and one way of explaining this 
observation biosynthetically is illustrated in scheme 2.9. 
However, this theory does not account} for the reduced 
enrichment of C-7' and the incorporation of label from 
(1-13Cjpropionate (12'2) solely'into'this position, C-7''. A 
possible further test would be to try incorporating- 
3-hydroxypropionate (123) into pseudomonic acid as this 
would be a precursor by this proposed route. 
2.8 INCORPORATION OF Sodium [1-13C)BICARBONATE ' 
To try to account for the reduced enrichment of C-7' from 
acetate, it was decided to see if this carbon atom could be 
derived from another source. Incorporation of 
13C- 
bicarbonate was tried to see if C-7' was derived via this 
'c-1 pool' as well as from acetate, and so could account'for 
the observed reduced enrichment level. The chalk used to 
buffer the second stage medium (required'to limit glucose 
uptake by the bacterium because `"if glucose' utilization is 
37 
r 
too rapid the bacteria quickly die) was replaced by 
13C 
labelled bicarbonate. Unfortunately, the pH of the culture 
supernatant had fallen to 4 during the course of the 
fermentation, and this is unusually low. Isolation of the 
metabolite was carried out in the normal way and 20mg of a 
colourless oil was obtained. The 
13C 
nmr of this isolate 
showed it to be methyl pseudomonoate but when compared with 
a natural abundance 
13C 
nmr spectrum, determined under 
identical conditions, no enrichment was observed. 
Consequently, nothing more can be said from this negative 
result as to the origin of C-7' and to the role of malonate 
in pseudomonic acid biosynthesis. 
2.9 INCORPORATION OF SODIUM [1-13C]ACETATE 
it was decided to check the previous workers16 findings, 
that feeding [1-13C]acetate resulted in reduced enrichment 
at C-7', since this has important implications for the role 
of malonate in this biosynthetic pathway. Sodium 
[1-13C]acetate (200mg, 2.4mmol) was fed to a growing second 
stage culture, and production of the methyl pseudomonate was 
good (40mg). Analysis of the 
13C 
nmr spectrum of this 
enriched metabolite did reveal 
13C 
enrichment in all the 
expected sites (table 2.10). These were calculated as 
described previously for the di-sodium (2-13C]malonate 
incorporation experiment. However, incorporation was at a 
much lower level (1.5x natural abundance) than that found by 
the previous workers16 (7x natural abundance). In a repeat 
experiment to try to increase enrichment levels, the 




nmr enrichments observed in the 75.47MHz 
13C 
nmr from 
methyl pseudomonate enriched from [1-13C]acetate. 





1 166.76 1.5 2.2 
3 156.62 1.4 2.2 
5 74.85 1.4 2.1 
7 70.34 1.5 2.2 
9 31.60 1.0 2.0 
11 61.30 1.5 2.4 
13 71.32 1.7 2.6 
1' 174.34 1.7 2.8 
3' 24.90 1.5 2.3 
5' 29.00 1.3 1.6 
7' 25.94 1.5 1.3 
9' 63.82 1.4 2.1 
a 200mg [1-1C]acetate 
b 500mg [1- 
3 
C]acetate pulse fed 
100mg (1.2mmol) was added to 250mg of growing second stage 
culture after 10h, 14h, 22h, 26h and 30h. To prevent 
abnormal changes in the pH during the fermentation, 
resulting from these acetate feeds, the second stage medium 
was 'buffered on the alkaline side by increasing the chalk 
concentration and the amount of Na2HPO4 and reducing the 
amount of KH2PO4 present. 
Analysis of the 
13C 
nmr spectrum of the isolated enriched 
sample, from this incorporation experiment, again showed all 
the expected sites to be labelled. Enrichment levels, which 
were calculated by the method as outlined for the previous 
experiment, were better (twice natural abundance) but still 
less than the observed enrichment levels found by previous 
workers16. However, C-7' was shown to be less enriched than 
the other sites (table 2.10). This confirms the earlier 
findings but does not give any more information which can be 
used to explain the observed enrichment pattern from 
[2-13C]malonate. 
2.10 SYNTHESIS OF Sodium [1-13C]PROPIONATE AND DOUBLY 
LABELLED 9-HYDROXYNONANOIC ACID 
For future studies, [1-13C]propionate (122) and doubly 
labelled 9-hydroxynonanoic acid (3) will be required. The 
synthetic route to [1-13C]propionate is based on Cane's39 
synthesis of [l- 
13C, 1802]propionate. The synthetic route to 
9-hydroxynonanoic acid was developed from literature 
preparations of the intermediate compounds, with the req- 
uirement to have a step for introduction of radioactive (14C 
39 
KCN 
CH CH CN 
t(BUO)C 
CH3C 2I McOHýtt) 32 tBuOH 
(124) 
e® CH3CH2CO2K 








The incorporation of [1-13C]propionate will be used to test 
the previous findings16 that it is solely incorporated into 
C-7'. This is important since, the unusually low 
incorporation of [1-13Cjacetate into C-7', compared to the 
enri. chment levels at all other labelled sites requires 
further investigation, especially in the light of the 
(2_13C]malonate observed 
13C 
enrichments in the 
9-hydroxynonanoic acid side chain. 
To further test the theory that pseudomonic acid is 
synthesised from preformed C'17 and C9 subunits, the 
incorporation of 9-hydroxynonanoic acid into pseudomonic" 
acid should be studied. This could be achieved by feeding 
9-hydroxynonanoic acid radio-labelled with 
14C in the acid 
group and 
3H in the CH2 group adjacent to the hydroxyl 
group. If this precursor is incorporated intact into 
pseudomonic.:. acid then the ratio of 
14C/3H 
of the precursor 
to the ratio observed in the isolated metabolite should be 
the same. 
The synthetic route to (1-13Cjpropionate (122) is shown in 
scheme 2.10. Step one of this synthesis involves the 
preparation of (1-13C]propionitrile (124) from potassium 
cyanide and ethyl iodide in refluxing absolute methanol. 
This nitrile (124) was then hydrolysed by refluxing with 
tbutoxide in tbutyl alcohol. The-potassium propionate (125) 
generated was then converted back to the free acid before 

























N HO-C H2-(CH2)7-CO2Me 
(135) 





required sodium (1-13C]propionate (122). It should be noted 
that the original prepartion stated that this should be 
lyophilized, but if this is done then the free propionic 
acid generated is lost: The 
1H 
nmr spectrum of the 
(1_13C]propionate again showed the coupling effects of 
directly bonded and remote hydrogens, the resonance for the 
methyl signal at 61.0 is now a multiplet due to three bond 
1H-13C 
coupling, and the methylene signal is also a 
multiplet due to two bond, 
1H-13C 
coupling. I 
The synthetic route to the doubly labelled 9-hydroxynonanoic 
acid is detailed in schemes 2.11 and 2.12. Scheme 2.11 
indicates how the 14C label is introduced into the acid 
group of 9-hydroxynonanoic acid and scheme 2.12 indicates 
how the 3H label is put in place. This will be done to avoid 
carrying labelled material through such a long reaction 
sequence. The 
14C is first introduced as indicated in 
scheme 2.11 and then the synthesis is repeated with 
unlabelled potassium cyanide through to point where the 
3H 
label is introduced from'sodium borotritiide (scheme 2.12), 
and the doubly labelled compound required for feeding would 
come from an equal mixture of 
14C labelled material (129) 
and the 
3H labelled material (135) - the ratio of 
14C/3H 
being determined from this mixture. 
This synthesis starts from 8-bromo-l-octanol (127) which is 
converted to the corresponding nitrile35 (128) by reaction 
with potassium cyanide in aqueous methanol. The nitrile 
(128) was then hydrolysed36 to 9-hydroxynonanoic acid (129) 
by reaction with potassium hydroxide in methanol. 'The 
14C 
41 
label will come from potassium -[14C]cyanide. The 
9-hydroxynonanoic'acid (131) was then treated with an excess 
of ethereal diazomethane (generated'as detailed previously) 
to form 9-hydroxynonanoate (132), and this. was then 
oxidised37 to the corresponding aldehyde (133)" by' reaction 
with pyridinium -chlorochromate (PCC). " This was then 
re-reduced to the alcohol using 'sodium -borohydride38, and 
for the introduction of 
3H, 
sodium borotritiide'would be 
used, and finally, hydrolysis of the resulting hydroxy ester 
compound (134) results in 9-hydroxynonanoic acid (135). 
1H 
nmr spectroscopy was used to determine the structures of the 
generated intermediate compounds. ' Before this route can be 
used to synthesise radio-labelled 9-hydroxynonanoic- acid, 
the step which introduces the 
3H label will have to be 
optimised. The conversion yield of 29% is unacceptably low 
fora labelled synthesis. 
2.11 FURTHER WORK 
After optimising the re-reduction step, for the introduction 
of 
3H into the doubly labelled 9-hydroxynonanoic acid, 
incorporation studies could then be carried out and should 
provide more information on the biosynthesis of the 
9-hydroxynonanoic acid side chain and its coupling-to monic 
acid. Intact incorporation of this precursor would support 
the previous theory16 of separate subunits that are 
synthesised shortly before being used to generate the final 
metabolite, ' whilst non-intact incorporation, might suggest 
that this side chain is synthesised by stepwise assembly 
intermediates onto monic acid. More information onn the role 
42 
V 
of malonate in this biosynthetic pathway might come from 
studying the incorporation of 3-hydroxypropionate, which 
would be a precursor if the proposed route outlined, (scheme 
2.9), is correct. The 3-hydroxypropionate' could be 
synthesised by a low temperature condensation reaction 
between ethyl formate and the enolate of ethyl acetate. A 
13C label could thus be conveniently introduced from sodium 
acetate by its conversion to ethyl acetate31 which is 
subsequently used to synthesise the required 
3-hydroxypropionate. The origin of C-7' could be further 
investigated by re-feeding [l-13C]propionate to check the 
initial published result16 and also determining the labelling 
pattern from (2- 
13C]propionate, 
which could be synthesised 
by the method outlined by Nefkens and Zwanemburg40. This 
might also lend further information on the role of malonate 
in this pathway. It might also be worthwhile, testing to 
see if leucine plays any part in the biosynthetic pathway to 
pseudomonic acid. The role of leucine in terpenoid 
metabolism has been investigated by Overton et a1. These 
34 
workers found that (3S)-3-hydroxy-methyl-glutaryl-COA (HMG 
CoA) from leucine breakdown was not incorporated directly 
into mevalonic acid (MVA) but acetyl CoA and acetoacetate 
produced by leucine breakdown, via HMG-CoA are subsequently 
incorporated into HMG-CoA and MVA. MVA is not a known 
precursor to pseudomonic acid but HMG-CoA was suggested as 
being one, even although no evidence for intact 
incorporation was found in this work. This result. is 
similar to these workers findings for terpene biosynthesis, 
but pseudomonic acid is basically polyketide in origin, so 
it would not be correct to draw too many similarities 
43 
between these two results. However, a trial incorporation of 





Melting points were determined on a Ko: Fler hot stage 




nmr spectra were 
determined on various instruments, namely, Bruker WH400, 
Bruker WH360, Bruker WH300, WP200SY and WP80SY 
Fourier-transform Spectrometers, and were referenced on 
deuterated solvent, or on TMS. In the case of 
2H 
nmr 
spectra these were referenced on chloroform. Routine 
1H 
nmr spectra were obtained on a Varian EM390 or on a Joel 
JNM-PMX 60 continuous wave spectrometer. Mass spectrometry 
was carried out on a' Kratos MS 50, or AEI MS 902 
spectrometer, with ionisation being achieved by electron 
impact. Optical rotations were recorded on a Perkin Elmer 
141 polarimeter. Infra red spectra were . recorded on a 
Perkin Elmer 781 spectrophotometer and were referenced 
against the polystyrene absorption at 1603cm 
1. Gas 
chromatography was carried out on a Pye 204 chromatograph. 
Preparative thin layer chromatography was carried out on 
glass plates (20 x 20 cm), coated with a 0.5mm layer of 
silica gel (Fluka 60765 Kieselgel Gf254). Bands were 
visualised using ultra violet light (254nm). Flash 
chromatrography was carried out on silica gel 400 - 200 mesh 
(Kieselgel 60 Merck). 
Scintillation counting was carried out on a Beckmann LS7000 
liquid scintillation counter. Programme four was used 
without automatic quench correction, butyl PBD (10g/1) in 
45 
methanol-toluene (50: 50) was used as the scintillant. The 
counting efficiency was determined by using both standard 
channels ratio and H-number quench curves. 
All solvents were of commercial grade and used without 
purification unless stated otherwise. Purification and 
drying of solvents was carried out by the procedures 
outlined by Perrin and Armarego, in " Purification of 
Laboratory Chemicals62". A dry N2 atmosphere was obtained by 
passing compressed N2 gas through a series of traps 
containing; 
(i) concentrated sulphuric acid 
(ii) glass wool 






FERMENTATION OF P. FLUORESCENS (NCIB 10586) AND ISOLATION 
OF PSEUDOMONIC ACID 
FERMENTATION MEDIUM 1 
The bacterium was maintained on nutrient agar slopes, 
stored at 4°C and subcultured every 2 months. For 
inoculation, a slope was flooded with nutrient broth, iml of 
which was added to a seed stage flask. This seed stage 
medium (used to obtain good bacterial growth) consisted of; 
Oxoid nutrient broth (13g), peptone (5g), Na2HPO4 (2.6g), 
KH2PO4 (2.4g), and glucose monohydrate (l. lg), made up to 11 
with distilled water. The pH of the medium was adjusted to 
7.0 with 2M NaOH, dispensed into 500ml flasks (100ml/flask) 
and sterilised at 121°C and 151b in-2 pressure for 15 min). 
The culture was incubated at 26°C for 24h. A sample (10ml) 
of this seed stage served as inoculum for the second 
(production) stage medium (100ml/500m1 flask) which 
consisted of; KH2PO4 (0.4g), Na2HPO4 (0.65g), KC1 (0.5g), 
MnCl. 2H20 (0.003g), MgSO4.7H20 (0.375g) and ground nut meal 
(21g) made up to 11 with distilled water. Again, the. pH was 
adjusted to 7.0 prior to sterilisation at 121°C and 151b 
in-2 for 15min). Immediately after inoculation a sample 
(10ml) of 5% glucose in water (separately sterilised at 151b 
in-2 for 15min) was added. Incubation was carried out at 
26°C for 24h on a rotary shaker. 
FERMENTATION MEDIUM 2 
For inoculation of the seed stage flasks using this set of 
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fermentation conditions, one culture slope' of P. `fluorescens 
was flooded with nutrient broth. A sample (lml) of this, 
was added to a seed stage flask (50m1/250m1 flask-) 
containing yeatex (28.5g), glucose (l. lg), Na2HPO4 (2.6g), 
KH2P04 (2.4g), and (NH4)2SÖ4{ (5.0g), ` made up to 11 with 
distilled water (the pH adjusted to 7.0 with 2M NaOH before 
sterilisation at 121°C and 151b in-2 for 15 min). This 
culture was incubated' at 25°C for 24h on a rotary shaker. 
iml of this seed stage was then used to inocülate''each 
second (production) stage flask "(25ml/250ml flask)' 
containing; Arkasoy 50 (20g)', corn steep` liquor (5.0g)', 
(NH4)2504 (5.0g), -MgSO4" 7H2O (0. Sg), Na2HPO4 (l. Og), ' KH2P04 
(1.5g), antifoam (L-81) (a few"'drops), CaCO3 (6.25g/11) and 
glucose (60g) made up to 11 with distilled water and the pH 
again adjusted to 7.0' before sterilisation at 117°C, 151b 
in-2 for-.: 15min. This medium was stirred constantly when it 
was dispensed into-the flasks to ensure even distribution of 
the chalk. - The culture was incubated at 22°C for 48h on a 
rotary shaker after which time production was essentially 
complete. 
MODIFIED CULTURE CONDITIONS " 
Due to the decline in-production of the metabolites, the 
storage and fermentation conditions had to be modified. The 
following changes were made: 
(1) Instead of maintaining the culture onmutrient agar 
slopes a nutrient deficient agar was used which 
slowed down any active growth and ageing--of the 
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bacterium on the slopes. These slopes are viable for 
3 months. 
(2) The culture was not subcultured. After 3 months, a 
fresh set of working slopes were` made -up and 
inoculated- from a" freeze-dried -isolate of", the 
bacterium. 
(3) In the' , second (production) stage of the fermentation, 
'baffle' or 'spiked' 250m1 flasks were used in place 
of Erlenmeyer flasks. These flasks increase the degree 
of aeration afforded to the growing culture by 
disrupting the circular motion of'the liquid'as it is 
shaken on the rotary incubator. This results-in 
increased titres of the metabolite. 
HPLC'ANALYSIS OF CULTURE FILTRATES 
AWaters N-bondapak C-18 column was used for this analysis. 
The eluting solvent was methanol/O. -05M ammonium acetate 
(3: 2, v/v), pH 4.5. The flow rate was 1.5m1/min and uv 
detection was at 230nm. Pseudomonic acid A has a retention 
time'of 6min and pseudomonic acid B has a retention time of 
5.5mirf. under these conditions. 
ISOLATION AND PURIFICATION OF METHYL PSEUDOMONATE FROM 
FERMENTATION MEDIUM 2 
The second stage flasks were harvested as follows: 
The cells were removed by centrifugation (10"000g) at 2°C. 
The pH of the combined supernatants (ca 250m1) was then 
adjusted to 4.5 with 2M HC11 saturated with NaCl and 
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extracted - with 100ml of ethyl acetate. The layers were 
separated and the aqueous layer extracted with ethyl acetate 
(4x 100ml)`. 'The organic extracts were combined, dried over 
anhydrous MgSO4 and the solvent evaporated in vacuo to yield 
a yellow/brown oil. This was dissolved in 5ml methanol and 
treated-with an excess of ethereal diazomethane. This was 
stirred at room temperature for approximately 2h and after 
this time, any remaining- diazomethane was removed by' 
bubbling N2 through the solution. The solvent was 
evaporated in vacuo to yield an oil which was purified by 
preparative tlc (solvent system; ethylacetate/ethanol, 
40: 1). The band at rf 0.3 afforded methyl pseudomonate as a 
colourless oil which crystallised on standing`in the fridge. 
This showed signals at, 6H (CDC13,360.13MHz) 0.95 (3H, 'd, 
J-5Hz, 17-CH3) , 1'. 20 (3H, d, ' J-SHz, "14-CH3) ; 2.2 (3H, s, 
15-CH 3), 2.3 (2H, t, J-5Hz; 21-CH2), 3.65 (3H, s, ester 
CH3)1 4.1 (2H, t, J-5Hz, 9'-CH2), 5.75 '(lH, 's, "2-CH) The 
remainder of this spectrum was complex but identical to a 
spectrum of authentic methyl pseudomonate. 
SYNTHESIS OF DIAZOMETHANE 
This general preparation 'gives ä yield of 60%, ie. 0.03M 
solution"in diethyl ether. This 'preparation was carried out 
using glassware which had no ground glass joints. 
To a solution of ethanol (18ml) and diethyl ether (15ml) was 
added KOH (3g) in water (5m1), and this was warmed on 'a 
water bath to'60-70°C until the ether starts to distil. At 
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this point, a solution of Diazald, (10.75g) in diethyl ether 
(70m1) was added in portions over a period of 15 to 20 min. 
The diazomethane distilled over and was collected in a flask 
cooled in an ice-bath. Distillation was continued until the 
distillate was colourless. More diethyl ether was added to 
the reaction flask as required. The quantities of Diazald 
used in the preparation of the excess ethereal solution of 
diazomethane wear. reduced in portion to the yield of the 
isolated, _pseudomonic acid being methylated. 
GROWTH PRODUCTION STUDIES 
In all these studies, fermentation medium 2 was used, and 
inoculation procedures from culture slope to seed stage 
flask and from seed stage flask to second stage flasks were 
as described previously. . In each5. study, one first stage 
flask was grown up, and used to inoculate ten second stage 
flasks. At timed intervals, O. lml of culture fluid was 
removed, from all ten. flasks, combined., and after 
" micro-filtration was analysed by hplc,, against, a standard 
sample of pseudomonic acid of known concentration. Hplc 
assay conditions. were as previously described. Intial 
production of the metabolites occurs after 20h fermentation 
and reaches a maximum after 60h fermentation. Repetition of 
this experiment confirmed this result. 
After modifying the culture maintenance and fermentation 
conditions, the, production of, the - pseudomonic acids with 
time was checked again. The following changes were made in 
this growth production study:, - 
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(1) The second stage medium was contained in 'baffled' 250m1 
flasks. 
(2) The pH of the culture fluid removed at the set time 
intervals (O. lml/flask) was adjusted to 8 before the 
cells were removed by centrifugation. 
(3) The pH during the fermentation, -, was also followed with 
time. 
Analysis of the culture filtrates was by hplc -assay 
conditions 
were as described before. Pseudomonic acid is. produced from 
approximately 20h and fermentation is essentially complete 
after 48h., During the fermentation, as the glucose is-used 
up, the pH drops to approximately 4.5 before rising to a 
finishing pH Of 8.0. . 
. ý. 
LABELLED-PRECURSOR INCORPORATION STUDIES' 
All intial feeding studies, until indicated in the text, 
were carried out using the NCIB 10586 strain of P. 
fluorescens grown using fermentation media 2 and the intial 
maintenance and culture fermentation conditions outlined 
previously. The flasks were harvested and isolated 
pseudomonic acid was methylated and purified as described 
before. The control flasks for the following incorporation 
experiments, were monitored by hplc using the assay 
conditions outlined before. 
INCORPORATION OF SODIUM (1-14C]ACETATE 
In 3 -separate experiments, sodium (1-14Cjacetate as a 
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solution in distilled water (5ml) was filter-sterilised-and 
added to a growing second stage culture flasks of 
P. fluorescens at set time intervals, (detailed below). 
Each experiment used ten. second stage-flasks 0.5m1 (200mg, 
0.5pCi in 5ml of sterile water) of acetate solution was 
added to each flask. At the same time a set, ten second 
stager-flasks, were grown up as controls and the production 
of the metabolites monitored by hplc. After 60h the flasks 
were harvested as detailed previously. Yields of the 
isolated methyl pseudomonate from the three incorporation 
experiments are given below. The specific activity of each 
sample of the isolated methyl pseudomonate was determined by 
liquid scintillation counting. ' The results are summarised 
below. 
FERMENTATION TIME YIELD SPECIFIC ACTIVITY DILUTION PER 
LABELLED SITE 
(h) (mg) (dpm/mmol) 
10 30 6.44X104 848 
15 20' 2.40x105 22.7 
20 15 1.94x106 0.28 
CONTROL 50 ý- - 




In two separate experiments, 200mg of each of the labelled 
acetates were fed after 20h fermentation to ten second stage 
flasks. The fermentation conditions are as detailed before. 
The flasks were harvested after 48h, again as detailed 
previously, to yield methyl pseudomonate as a colourless 
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oil. The [1-13C, 
2H3]acetate feed- yielded '25mg and the 
(1-13C, 1802]acetate feed yielded 19mg. 
MEASUREMENT OF OXYGEN UPTAKE BY P. FLUORESCENS AND 
180 
INCORPORATION 
Ten second stage flasks were set up `using the conditions 
1 
outlined and connected to the 
802 "closed" system apparatus 
(figure 2.7) by means of flexible tubing. The oxygen uptake 
by the culture was measured with time, giving the results 
detailed below. The flasks were harvested after 74h 
fermentation time and after purification yielded 110mg of 
methyl pseudomonate as a colourless oil. - 
1H 
nmr spectrum 
was identical to one determined from an authentic sample of 
methyl pseudomonate. 












Total oxygen uptake was 5.3 litres. 
For the 
1802 incorporation experiment, five second stage 
flasks were used and were connected to the 
1802 
apparatus 
after 24h growth, in'time for the phase of maximum oxygen 
uptake by the culture (this oxygen uptake with time is 
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detailed below). The flasks were' harvested after 44h'" 
growth, after which time oxygen usage by the culture-had 
levelled off. This yield 8mg of a white solid. The, 
1H 
nmr 
spectrum of this isolated material was identical to one 
determined from an authentic sample of methyl pseudomonate. 













" 44.0 2650 
0 
The total 18Oxygen uptake was 2.1 litres. 
SYNTHESIS OF ß-HYDRORY-ß-METHYL GLUTARIC ACID 
Sodium acetate (112), (lg, 12mmol) was mixed with tri-nButyl 
phosphate (4m1) and heated under reflux for 2h at 200-220°C. 
The resulting viscous mixture was cooled to room 
temperat<; --, re and the upper end of the reflux condenser was. 
sealed through a line containing two traps to a vacuum pump 
and the product ester was distilled by heating the reaction 
flask to 160°C for 2.5h. nButyl acetate (114) was collected 
in the second trap which was cooled by liquid N2. Any 
tri-nButyl phosphate which distilled was collected in the 
first trap which was cooled by an ice%salt bath. 
6H (CDC13,80MHz) 0.9 (3H, t, J-6Hz, CH3)1 1.5 (4H, in, 
J-6Hz, 2xCH2), 2.0 (3H, s, CH3)', 4.0 (2H, 
t, J=6Hz, OCH2). 
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nButyl acetate (113) (1.23g, 10.6mmol) and allyl bromide 
(3.85g, 2.7ml, 31.8m1) in a 3/7, v/v mixture of anhydrous 
diethyl ether/dry THE (50m1) was added to dry magnesium 
turnings (1.0g, 42.4mmol) in 10ml of the diethyl ether/THF 
solvent, at such a rate that a moderate reflux was 
maintained. After the addition was complete, the reaction 
mixture was refluxed for ih at 60°C and then stirred at room 
temperature for 5h. Ice (approximately 100g) was added to 
the reaction flask which was also cooled in an ice bath 
before being acidified with 6M H2SO4. The acid solution was 
stirred at room temperature overnight and then extracted 
with ether (3x 50m1). The combined ethereal extracts were 
washed with saturated NaHCO3 solution, water, brine and then 
dried over anhydrous MgSO4. The solvent was removed in 
vacuo and the crude product distilled under reduced pressure 
to yield 4-hydroxy-4-methyl-hepta-1,6-diene (114) (1.57g, 
12.4mmol) as a colourless oil. (Bp. 75-80°C, water pump 
pressure). 
SH (CDC13,80MHz) 1.18 (3H, s, CH3)1 1.8 (1H, s, 
exchangeable OH), 2.23 (4H, d, J-7Hz, 
2xCH2), 5.0 - 6.0 (6H, m, vinyl protons) 
The diene (114), (1.57g, 12.4mmol) was taken up in 30m1 of a 
10: 1, v/v solution of dichloromethane/acetic acid and cooled 
to -78°C before being subjected to ozonlysis for 1.5h. - The 
resulting solution was left to stand at room temperature 
overnight. The solvent was carefully removed in vacuo at 
30°C. To the resulting colourless gum was added acetic acid 
(30m1) and hydrogen peroxide (16m1,50 vol). This mixture 
was heated under reflux for 24h. The yellow solution was 
56 
then cooled to room temperature and the "solvent evaporated 
in vacuo. The resulting semi-solid residue which formed on 
standing at room temperature was recrystallised 'from 
acetone/chloroform to yield 
3-hydroxy-3-methylpentan-1,5-dioic acid (ß-hydroxy-ß-methyl 
glutaric acid) (115), '(1.2g, 7.4mmol). Mp - 108-'110°C 
(1it29(a) 110-111°C) 
aH (d6 acetone, 80MHz) 1.38 (3H, s-, 'CH3), 2.68 (4H, s, 
2xCH2), 6.15 (ca. 2H, br s, 2xCO2H) 
A solution of (115) (0.6g, 3.7mmol) was converted to the 
diethyl ester by treatment with a large excess of HC1 
saturated ethanol solution. This was stirred at room 
temperature for 24h. The solvent was evaporated in vacuo 
and the residue taken up in ethyl acetate and washed with 
water (3x 20m1). The ethyl acetate extract was dried over 
anhydrous MgSO4 and the solvent evaporated in vacuo to yield 
the diethyl ester (117) (0.65g, 2.98mmol', 81%) as an oil. 
SH (CDC13,60MHz) 1.0 (3H, t, J-6Hz, CH3), 1.2 (3H, s, CH3), 
2.7 (4H, s, 2xCH2), 4.0-4": 5 (4H, q, J-6Hz, 
2xOCH2) 
The diacid (115), 0.6g (3'. 7mmol) was taken up in 5ml of 
water and converted to the di-sodium salt by neutralisation 
with 2M NaOH (3.7ml). This solution was stirred at room 
temperature overnight and then freeze-dried to yield the 
di-sodium salt (116) 0.72g (3.6mmol, 97%) as a white solid. 
SH(D20,80MHz) 1.3 (3H, s, CH3), 2.4 (4H, s, 2xCH2). 
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SYNTHESIS OF (3-14C]-ß-HYDRORY-ß-METHYLGLUTARIC 
ACID 
This radio-labelled ester was prepared as described above 
for the unlabelled synthesis. Sodium acetate lg (specific 
activity 125pCi/g) was reacted with tri- nbutyl. phosphate 
(4m1), to give the labelled nbutyl acetate (1.23g, 10.6mmol, 
88%). This was then reacted with allyl bromide (3.85g, 
2.7m1,31.8mmol) in 1.5m1 of a 3/7 v/v mixture of anhydrous 
diethyl 'ether/THF and magnesium (lg, 42.4 mmol). This 
product was then used directly in the ozonolysis reaction 
and subsequent oxidative workup to yield 
[3-14C]-ß-hydroxy-ß-methylglutaric acid (800mg, 5. lmmol). 
This was re-crystallised from acetone/chloroform to yield 
600mg (3.8mmol, 36% overall from 'butyl acetate). The 
specific activity of this compound as determined by liquid 
scintillation counting was 9pCi (1.09x107 dpm/m'mol). 
This labelled glutaric acid (202mg, 1.3mmol), was converted 
to the diethyl ester by reaction with an excess of HC1 
saturated ethanol. The solution was stirred at room 
temoperature for 24h and the solvent was evaporated in 
vacuo. The residue was taken up in ethyl acetate and washed 
with water (3x 10ml), dried over anhydrous MgSO4 and the 
solvent removed in vacuo to yield the diethyl ester (250mg, 
1.2mmol, 92%) as a brown oil. 
(3-14C]-ß-hydroxy-ß-methylglutaric acid, (400mg, 2.6mmol), 
was converted to the di-sodium salt by the method outlined 
previously for the synthesis of the unlabelled compound. 
This yielded (505mg, 2.5mmol, 96%). 
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SYNTHESIS SODIUM [3,6-13C2J-0-HYDROXY-0-METHYLGLUTARATE 
This was accomplished by the route outlined previously for 
the unlabelled compound. [1,2-13C2]nButyl acetate was 
generated'from sodium [1,2-13C2]acetate lg, (90 atom %) 
reacted with tri-nbutyl phosphate (4m1). This yielded the 
labelled nbutyl acetate, 1.16g (l0. Ommol, 82%). 
[3,6-13C2]-4-Hydroxy-4-methyl-hepta-1-6-diene was generated 
by reacting the labelled nbutyl acetate (1.16g, 10mmol) in a 
Grignard reaction using allyl bromide (2.56m1,1.42g, 
30mmol) and magnesium (0.96g, 40mmol) with dry diethyl 
ether/THF (3/7, v/v) as the solvent. This yielded the 
labelled diene, 1.558 (12.3mmol), as a brown oil which-was 
used directly in the ozonolysis reaction to. -form 
[3,6-13C2]-ß-hydroxy-ß-methyl glutaratic acid after. 
oxidative workup with hydrogen peroxide and glacial acetic 
acid. The. crude product was- re-crystallised-: from - 
acetone/chloroform to yield 0.8g (5. lmmol), as an off white 
solid. v 
SC (d6 acetone, 90.56MHz) 26.2 (q7 d pent, JC_H=127Hz, 
JC_C'40Hz, JC-C-C-H'5Hz, C-6) 
69.4 (d oct, Jcc'40Hz, JCCCH=5Hz, 
C-3) 
SH (d6 acetone, °200.13MHz) 1.38 (3H, " dd, JCH-121Hz, 
JHCCCH'SHz, CH3) . 
2.68 (4H, dd, JHCCCH'5Hz, 2xCH2) 
5.5 (2H,, br s, 2xC02H). 
This 13C2' labelled compound was also converted to the 
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di-sodium salt, by the method, outlined previously for 
feeding studies. This 
yielded 0.97g (4.8mmol, 95%). 
INCORPORATION OF SODIUM AND DIETHYL 
[3-14C]-ß-HYDRORY-ß-METHYLGLUTARATES 
In separate experiments; 
(1) 250mg ofýdi-sodium (3-14C]-0-hydroxy-ß-methyl glutarate 
as a solution in 10ml sterile, water, (lml/flask) and 
(2) 250mg of diethyl [3_14C 1-0-hydroxy-0-methylglutarate as 
a solution in 0.5ml ethanol (0.05m1/flask) I 
were each fed to ten second stage flasks, set up as; detailed 
previously, after 20h fermentation. The specific activity 
of these precursors was 1.98xl07dpm/mmol. -The flasks-were 
harvested after 48h-fermentation. Yields, ýspecific, activity 
of the isolated metabolite and dilution values (assuming 2 
labelled sites are detailed below. 
PRECURSOR YIELD SPECIFIC ACTIVITY DILUTION 
'- mg ,. (dpm/mmol) 
(1) Di-sodium 24 9.32x10 4.2 
salt feed 
(2) Di-ethyl 202.74x106 14.4 
ester feed 
INCORPORATION OF DI-SODIUM 
[3,6-13C2]-9-HYDRORY-ß-METHYLGLUTARATE ' 
For this incorporation study, - the modified culture 
conditions were used. Ten second stage culture flasks were 
set up as, described previously. 250mg (as a solution in 
10ml sterile water) of this precursor was added to this 
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growing culture after 20h fermentation (lml/flask). After 
40h fermentation, the flasks were harvested, and worked up 
as described previously, to yield 43.3mg of a white solid. 
SYNTHESIS OF DIETHYL MALONATE 
Freshly distilled triethyl phosphate (7.5ml) was added to 
sodium acetate (2.0g, 24.4mmol) and the mixture refluxed at 
170-185°C for 3h. The reaction mixture was cooled and then 
the upper end-of the reflux condenser was sealed to a vacuum 
line via a two trap line. The reaction mixture was then 
warmed to 120°C (0.6mbar) and the ethyl acetate (118) was 
collected in the second trap which was cooled by liquid N2. 
Any triethyl phosphate which 
distilled was collected in the firsttrap. which was cooled 
by ice/salt bath. This yielded. 1.84g of (118) (2lmmol, 86%) 
6H (CDC13,80MHz) 1.2 (3H,. t, J-8Hz, CH3), 2.0, (3H, s, CH3), 
4.18 
,. 
(4H, q, J-8Hz, CH2) 
nButyl lithium 17., 5ml (as a 1.6M solution in hexanes 
(28mmol)), _was added to,, a stirred solution of 
hexamethyldisilane (HMDS)-(4.71ml, 3.01g, 22.4mmol). in 30m1. 
dry THE at -70°c. under a, N2 atmosphere. The solution was 
allowed to warm slowly to 0°c and then re-cooled to -70°c. 
Ethyl acetate, 1.4g (1.5ml, -, 15.3mmol). was dissolved-in 4m1 
of dry THE and was added dropwise to the reaction mixture 
and the resulting mixture was stirred for 30min at -70°c. 
Ethyl chloroformate (1.7g, 1.8m1,18.4mmol) was then added 
keeping the temperature below'-550c. After a further 2.5h at 
-70°c, 6M Hcl (4ml) was added along with water (20m1) and 
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diethyl ether (100ml). The organic and aqueous layers were 
separated and the aqueous layer further extracted with 
diethyl ether -(50m1). The diethyl ether extracts were 
combined, washed with 3M HC1 (20m1), 5% NaHCO3 (50m1) and 
dried over anhydrous MgSO4. The solvent was removed in 
vacuo to yield diethyl malonate (119) (2.1g, 13.1mmol,. 86%). 
SH. (CDC13,80MHz) 1.25 (6H, t, J-6Hz, CH3) , 3.32 (2H, s, 
CH2) 4.18 (4H, q, J=6HZ, CH2) 
SYNTHESIS OF DI-SODIUM-MALONATE 
Conversion of this diethyl ester to the di-sodium salt was 
achieved as follows; 250mg (1.56mmol) of diethyl'malonate 
was taken up in 5m1 of water and titrated with 0.1M NaOH 
solution using an automatic titrating apparatus. The 
starting pH was 11.80 and as hydrolysis proceeded it-was 
maintained by automatic addition of the NaOH solution. The 
volume of NaOH taken up during the hydrolysis was 28.89m1" 
(theoretical amount required was 31.6m1). The aqueous 
solution was washed with n-hexane (3x 10ml) and then the 
hexane extracts were combined and back extracted with water 
(20m1). The aqueous extracts were combined and freeze-dried 
to yield di-sodium malonate (120) (186mg , 1.45mmol, 93%)-as 
a white solid. ýn 
vmax (KBr) 1244cm-1,1387cm-1 C-0 stretches, 1605cm-1 enol 
C-C stretch, 1717cm-1 carbonyl stretches 
SH (D20,80MHz) 2.9 (2H, s, CH2) 
SYNTHESIS OF DIETHYL [2-13C]MALONATE 
This labelled compound was prepared as described for the 
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unlabelled synthesis. Sodium [2-13C]acetate, 2g (24.4mmol, 
90 atom %) was converted to ethyl acetate by reaction with 
triethyl phosphate (7.5m1). This yielded ethyl 
[2_13C]acetate, (1.84g, 21mmol, 86%). 
6H (CDC13,80MHz) 1.2 (3H, t, J-8Hz, CH3), 2.0 (2H, d, 
JC_H-129Hz, CH3), 4.18 (4H, q, J-8Hz, CH2) 
This labelled ethyl acetate was then converted to diethyl 
(2-13C]malonate by using HMDS (5.3ml) and nbutyl lithium 
(23m1), (1.4M solution in n-hexanes). in dry THE, to 
generate the enolate of ethyl acetate which was then 
condensed at -78°C with ethyl chloroformate (1.45m1,1.65g, 
13 17.84mmol). This produced diethyl [2-C]malonate (1.88g, 
11.7mmol, 76%). 
SH (CDC13,80MHz) 1.25 (3H, 
JC_H-130Hz, 
CH2) 
This labelled diethyl malonate, (250mg, 
converted tö the corresponding di-sodium 
titration with l. OM NaOH solution. The 
solution taken up was 2.3m1 (theoretical 
3m1). After workup, as described previ 
[2-13C]malonate as a-white solid, (179mg, 
obtained. 
t, J-6Hz", CH3) , 3.4 " (211, 
d, 
13CH2)', 4.15 (4H, q, J-6Hz, 
1.56mmol), was 
salt by automatic 
volume of NaOH 
volume required - 
ously, di-sodium 
1.4mmol, 90%. ), was 
SH (D20,250.13MHZ) 3.09 (2H, d JC_H=130Hz, CH2) 
This synthesis was repeated with more diethyl 
(2-13C]malonate, (250mg) to give di-sodium "(2-13C]malonate 
(186mg). 
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This synthesis was again repeated using l. l4g'(7.2mmol) of 
the labelled diethyl malonate. This time, the 'diethyl 
malonate was taken up in water (20m1) and 2M NaOH (7.2ml) 
was added. The resulting solution was stirred at room 
temperature overnight. The aqueous' solution was washed with 
n-hexane (3x 10ml) and then the hexane extracts were back 
extracted with water. The aqueous-extracts were combined 
and freeze-dried to yield (7.2mmo1')'of a white solid. '' The 
1H 
nmr spectrum was identical to an authentic spectrum. 
INCORPORATION OF DIETHYL (2-13C]MALONATE 
Diethyl [2-13C]malonate (250mg) was fed'as a solution in iml 
of ethanol to ten second stage flasks (0.1ml/flask) after 
20h fermentation., The modified fermentation conditions were 
used for this study. The flasks were harvested after 40h 
fermentation and 50.5mg-of a white solid was isolated. 
INCORPORATION OF DI-SODIUM [2-13C]MALONATE 
(1) Using the modified culture conditions, ten second stage 
flasks' were set up and after 20h fermentation, 
di-sodium (2-13C]malonate (250mg) was added to this 
'growing culture. - This labelled precursor was fed as a 
solution in 10ml of sterile water at a level of 
lml/flask. '- The flasks were harvested after 40h growth 
and yielded 22.6mg of a white solid. 
(2) 1.07g of this labelled precursor was fed as a solution 
in 10ml of sterile water to five second stage flasks 
(2m1/flask) after 20h fermentation. The modified 
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fermentation conditions were used. After 40h growth, 
the flasks were harvested and 30mg of a white solid was 
isolated. -- 
INCORPORATION OF SODIUM [13C]BICARBONATE 
In this incorporation experiment, the chalk which is used-to 
buffer the second stage of the fermentation, was replaced by 
13C labelled bicarbonate. 1g of this labelled bicarbonate 
was used to make up eight second stage fermentation- flasks 
(le. 0.125g/flask)., All other medium constituents were as 
outlined previously,, for the modified culture conditions. 
The inoculation procedures and, -fermentation conditions were 
as described--for the modified fermentation conditions. 
After 40h. growth-the flasks were harvested. The pH of the 
culture supernatant was abnormally low (pH 4). Extraction 
was--carried out as described previously, except the pH of 
the culture supernatant was unaltered. The isolated crude 
methyl pseudomonate was purified by preparative-tic and a 
band at rf 3.1 afforded 20mg'of a colourless oil which 
crystallised-on standing in the fridge. 
INCORPORATION OF SODIUM [1-13C]ACETATE 
(1) [1-13C]Acetate (200mg) as a-solution in 10ml of sterile 
water was fed:: to ten second stage flasks after 20h 
fermentation (iml/flask). Again, - the modified-culture 
and., fermentation conditions were used. After 40h 
fermentation these flasks were harvested, by the method 




(2) [1-13C]Acetate (500mg) was pulse fed to the growing 
culture. To prevent abnormal changes in the pH during 
fermentation, the second stage flasks were buffered on 
the alkaline side by increasing the chalk concentration 
to 7.5g/l-. and increasing the, amount'of Na2HP04 present 
to 1.5g/1 and decreasing the amount of KH2PO4 to 
1.0g/l. All other constituents were as- described 
previously for the modified culture and fermentation 
conditions. - The (1-13C]acetate was fed in five 100mg 
portions, in 10ml of sterile-water (lml/flask), after 
10,14,22,26, and 30h fermentation. The flasks were 
harvested after 48h fermentation and yielded, after 
-workup as described previously, 30mg of a white solid. 
SYNTHESIS OF SODIUM [1-13C]PROPIONATE 
(1-13C]Propionitrile (124) was obtained by reacting 
potassium (13C]cyanide, (lg, 15.15mmol), with ethyl iodide 
(2.38g, , 
1.22ml, 15.25mmol) in 5. Og absolute methanol to 
which water, 0.24ml, had been added. This suspension was 
refluxed at 70°C for 12h and then at 80°C forfa further 38h. 
The entire mixture was distilled, and mixed with water, 
0.58ml, and 17.88m1 of 0.85M potassium 
tbutoxide=in tbutyl 
alcohol-and then refluxed for 48h. The residue obtained 
upon the evaporation-of- the solvent was redissolved in 
distilled water and acidified with-phosphoric acid, ýand then 
distilled. The distillate was then titrated with NaOH and 




6H (CDC13,80MHZ) 1.0 (3H, t, JH-C-C-C=SHZ, 'CH32.2 (2H, 
JH-C-C-40Hz, CH2) 
SYNTHESIS OF 9-HYDROXYNONANOIC ACID 
To 8-Bromo-l-octanol (127), =(lg; 0.41ml, ' 2.4mmol) in- 
methanol (20m1) was added sodium-, cyanide (3.72g), as a 
solution in water (5m1). '- The resulting solution was heated 
under' reflux overnight. After cooling the' solution, the 
solvent-was evaporated in vacuo. The residue was taken up 
in ethyl acetate (25m1-) and washed with water. The ethyl 
acetate extract was"", then"dried and evaporated to dryness to 
yield 9-hydroxy-nonanitrile (128) (0.33g, 88%). The water 
layers were combined'and reacted'with bleach to destroy any 
unreacted sodium cyanide which had been extracted into it. 
SH (CDC13,80MHz) 1-2 (12H, br, 6xCH2), 2.3 (2H, t, J'SHz, 
CH2), 3.6 (2H, t, J-SHz, CH2). 
This 9-hydroxy-nonanitrile (128) (0.33g, 2.1mmol), was 
hydrolysed to the corresponding acid by reaction with 
potassium' hydroxide (0.44g, 7.9mmol, 3.8 equiv) in methanol 
(13ml) and water (5ml). This solution was heated under 
reflux overnight. After cooling, the solvent was evaporated 
in' vacuo. The residue was taken up in a 'small volume of 
water and cooled in an ice-bath before the pH was adjusted 
to, 1.0 by 'addition of 2M HC1. - This solution was extracted 
with ethyl acetateý(5x 20m1), dried over anhydrous MgSO4 and 
the solvent evaporated to yield 9-hydroxynonanoic acid 
(129), (0.28g, 1.6mmol, 77%). 
)67 
SH (CDC13,80MHz) 1-2 (12H, br, 6xCH2), 2.2 (2H, t, J-5Hz, 
CH2), 3.6 (2H, t, J-5Hz, CH2), 5.0 (2H, br 
s, 2xOH. 
9-Hydroxynonanoic acid (0.28g, 1.6mmol) was taken up in the 
minimum volume of methanol and reacted with an excess of 
diazomethane (generated as described previously). The 
resulting solution was stirred at room temperature for lh. 
Any unreacted diazomethane was removed by bubbling N2 
through the solutiuon. The solvent was evaporated in vacuo 
to yield a waxy solid. This was taken up in diethyl ether 
(10ml), and filtered. The filtrate was concentrated to yield 
methyl 9-hydroxynonanoate (132) as a yellow oil (0.15g, 
0.8mmol, 50%). 
6H (CDC13,80MHz) 1-2 (12H,, br, 6xCH2), 2.3 (2H, t, J=5H'z, 
CH2), 3.2 (1H, br s, OH), 3.6 (2H, t, 
J-SHz, CH), 3.7_ (3H, s, CH2 3). 
Methyl 9-hydroxynonanoate (132), (0.29g, 1.54mmol) was 
reacted with pyridinium chlorochromate (PcC) (0.5g, 
2.31mmol,, 1.5 equiv) in dry methylene chloride (iOml) in a 
conical flask. This solution was stirred at room 
temperature overnight. The resulting black solution was 
filtered through a silica plug to remove most of the 
chromium salts and the filtrate concentrated in vacuo to 
yield a dark green oil. This was further purified by 
preparative, tlc (solvent system, hexane: ethyl acetate, 4: 1, 
v/v) to yield, methyl. 9-oxononanoate,, (133) (0.28g, 1.5mmol, 
97%). 
SH (CDC13,80MHz) 1-2 (12H, br, 6xCH2), 2.3 (4H, m, 2xCH2), 
68 
3.7 (3H, s, CH3), 9.8 (1H, d, Ja5Hz, CHO). 
Methyl 9-oxononanoate, (133) (0.28g, 1.5mmol) was taken up 
in dry methanol (10ml) in a 50m1 round bottomed flask and 
reduced with sodium borohydride (0.09g, 2.25mmol). This was 
added slowly to'solution'. with stirring and the resulting 
mixture was stirred at room temperature for a further 1/2h. 
The solvent was removed in vacuo and ether: water (1: 1) was 
added. The layers were separated and the aqueous layer 
further extracted with diethyl ether (5x 20m1). The organic 
extracts were combined, dried and evaporated to yield methyl 
9-hydroxynonanoate (134), (0.08g, 0.43mmol, 29%). The 
combined aqueous layers were continuously extracted with 
diethyl ether overnight but this failed to improve the 
yield. 
SH (CDC13,80MHz) 1-2 (12H, br, 6xCH2), 2.3 (3H, br m, CH2 
and OH), 3.6 (2H, t, J-5Hz CH2), 3.7 (3H, 
s, CH3). 
To the methyl 9-Hydroxynonanoate (134), (80mg, 0.43mmol), in 
water (5m1) was added 2M NaOH (0.12m1). This solution was 
stirred at room temperature overnight, and then acidified 
with 2M HC1. This resulting aqueous solution-was extracted 
with diethyl ether (5x 20m1). The organic extracts were 
combined and dried and evaporated to dryness to give 
9-hydroxynonanoic acid (135), (0.06g, 0.35mmol, 81%). 
SH (CDC13,80MHz) 1-2 (12H, br, 6xCH2), 2.2 (2H, t, J-SHz, 
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Synthesis and Incorporation of Advanced Precursors 
3.1 INTRODUCTION 
In 1983, Cane39: proposed a unified mechanism for the 
biosynthesis of polyether antibiotics, based on the cascade 
cyclisation of a postulated polyepoxide intermediate derived 
from the corresponding polyenes. For example, if the 
formation of the polyketide chain of monensin (7) were to be 
analogous to fatty acid biosynthesis, then the necessary 
units of acetate, propionate, and butyrate should be 
condensed sequentially, with concurrent adjustment of 
oxidation and unsaturation, as illustrated in scheme 3.1. 
Therefore, the intermediate compounds (136) to (138) 
represent plausible five-carbon, eight-carbon and ten-carbon 
polyketide chain elongation intermediates, while premonensin 
(139) corresponds to triene intermediate 
41-43 
proposed to be 
the product of the polyketide synthetase enzymes. 
Previous attempts to study the incorporation of chain 
assembly intermediates in whole cell cultures have usually 
been frustrated by the breakdown of the precursors by 
catabolic enzymes before they could be incorporated intact 
into the final metabolite. However recently it has been 
found that thioester derivatives of presumed chain 
elongation intermediates can be incorporated, into macrolide 
antibiotics, in whole cell studies without prior 
degradation. For example, in tylactone (140) biosynthesis 
44 
using cultures of Steptomyces fradiae, both a six-carbon 
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precursor have been incorporated as the corresponding 
N-acetylcysteamine (NAC) thioesters into the metabolite. 
Similarly, the NAC thioester of a six-carbon 
propionate-propionate intermediate has been incorporated 
into the erythromycins A and B (141) and (142) by 
Saccharopolyspora erthraea45. 
This is stepwise polyketide chain assembly and differs from 
fatty acid biosynthesis in that it characteristically does 
not involve the systematic repetition of the same multi-step 
process in extending the carbon chain. Instead, each time 
carbon chain extension occurs, the resulting ß-keto 
thioester intermediate undergoes differing degrees of 
modification, for example, by reduction, dehydration, 
methylation or oxidation, before the next chain-extending 
reaction. 
3.2 A STEPWISE ASSEMBLY MECHANISM TO MONIC ACID 
For pseudomonic acid biosynthesis, a similar stepwise 
assembly of chain elongation intermediates can be proposed 
(scheme 3.2). According to this mechanism, enzyme bound 
acetyl CoA would condense with malonyl CoA to generate 
enzyme bound acetoacetate (144), which is then 
'* It stereospeci6cc methylated to intermediate (145). The 
g-ketone group 
ý'is 
then reduced to generate enzyme bound 
(2S, 3S)-3-hydroxy-2-methylbutanoic acid (146) or 
alternatively, both stereocentres may be generated in the 
reduction step. This intermediate (146) is further chain 
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intermediate (147), which is again modified by ketone group 
reduction to an alcohol, followed by dehydration to generate 
intermediate (149). This is further chain extended and 
modified in a stepwise assembly to eventually produce the 
intermediate precursor to monic acid (2). 
To test this stepwise assembly mechanism, it was decided to 
examine the incorporation of some of these proposed assembly 
intermediates. These chain-elongation intermediate 
compounds had to synthesised in labelled form with the 
correct stereochemistry. The compounds chosen for study 
were the acetoacetate intermediate (144), the 
(2S, 3S)-3-hydroxy-2-methylbutanoic acid intermediate (146) 
and the (4S, 5S, 2E)-5-hydroxy-4-methylhex-2-enoic acid 
intermediate (149). These compounds were all synthesised in 
the following three forms; (i) NAC thioesters, (ii) ethyl 
esters and (iii) sodium salts. This allows for comparison 
incorporation of the precursor by the cells into the final 
metabolite, whether intact or not. 
3.3 SYNTHESIS OF PROPOSED CHAIN-ELONGATION INTERMEDIATES OF 
PSEUDOMONIC ACID BIOSYNTHETIC PATHWAY 
The N-acetylcysteamine deriviative of acetoacetate (144), 
was synthesised as shown in scheme 3.3. Ethyl acetoacetate 
(151) was synthesised from acetyl chloride and ethyl acetate 
in a low temperature condensation reaction, using HMDS and 
nbutyl lithium to generate the enolate of ethyl acetate. 
Although, the ester (151) could be readily hydrolysed with 
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of the a=hydrogens and the free acid was also very 
susceptible to decarboxylation and all attempts to form the 
thioester (144) from the free acid using standard conditions 
were unsuccessful. 
An alternative approach, torthis compound (144)_. was tried. 
The N, S-di acetylcysteamine was readily synthesised fron 
2-mercäptoethylamine hydrochloride by Schwab and Klassen's 
procedure 
50. 
The dilithio_ deriviative 'pof 
N, S-diacetylcysteamine '(156), ^ which was generated by' 
reaction with LDA, was quenched with acetyl 
chloride. This should have led directly to the desired 
compound (144). However, this approach was unsuccessful 
with no trace of the thioester being'formed, although Ia 
similar NAC thioester of 2-methyl-3-oxobutanoic acid (158) 
1 
has been prepared recently5u sing this'' approach. Another 
route to' (144) was developed' based 'on the Yonemitsu method 




. This route is shown in scheme 3.4. In 
this synthesis, " the first step is to acetylate Meldrum's 
acid. A model reaction using a simpler thiol, cyclohexane 
thiol, was tried to'see if the thiolysis reaction would 
work. This did give the cyclohexane thiol' deriv'st. -tive of 
acetoacetate (161). However, when the reaction was repeated 
using'N-acetylcysteamine, the reaction was unsuccessful with 
free thiol being isolated as the main product. Increasing 
the reaction time also failed to produce the desired product 
(144). 
It was decided to re-examine the first route', scheme'3.3, 'to 
73 
the desired thioester (144). It was thought that protection 
of the ß-ketone group as a ketal 
might 
solve both problems 
of the acidity of the a-hydrogens and the unstability of the 
free acid to decarboxylation. This was achieved by reacting 
ethyl acetoacetate with ethylene glycol in refluxing benzene 
using a Dean-Stark apparatus, to yield ethyl acetoacetate 
ethylene ketal (152) in 75% yield. Hydrolysis of this ester 
with base went smoothly and this was then activated as a 
mixed anhydride (154) by reaction with methyl chloroformate 
for coupling to N-acetylcysteamine. This proceedure was 
adapted from thioester preparations described by 
Hutchinson. This did result in the protected form of the 
46 
desired thioester (155), in good yield (71%). Deprotection 
was achieved via a trans-ketalisation reaction using acetone 
and toluene-4-sulphonic acid. However, the reaction time 
was found to be critical with 2.5h being optimum before the 
thioester starts to decompose. The thioester was purified 
by flash chromatography. Intially, the running solvent was 
unbuffered but free thiol (157) was isolated and 
lH 
nmr 
spectrum of the crude product did not show this to be 
present intially, as there was no triplet signal at 51.5 
characteristic of the HS group. To counteract the slight 
acidity of the silica, the running solvent was buffered with 
a trace of triethylamine and this solved the problem of 
cleavage of the thioester group. 





nmr spectrum of ethyl acetoacetate 
(151) showed keto-enol tautomerism. Approximately 5% enol 















































































this is easily seen in the 
1H 
nmr spectrum. The keto-enol 
spectrum consists of signals from both tautomers. The major 
signals due to the keto form are easily assigned, and those 
of the enol tautomer are the singlet methyl signal at 81.9 
and the olefinic proton at ca. 65.1. The ethyl ester signals 
coincide for both tautomers. The final thioester (144) also 
shows similar keto-enol tautomerism. The 
1H 
nmr spectrum 
(figure 3.1) of this compound also showed characteristic 
thioester signals at 63.0 (CH2S) and 63.4 (CH2NH). In the 
free thiol, these signals are at S&. 7 (CH2SH) and 53.4 
(CH2NH). Mass spectrometry gave a molecular ion at m/z 204 
(M+) as further proof that this thioester had been 
sucessfully synthesised. This synthetic route allows for 
the introduction of a double 
13C label spanning the 
acetate-malonate junction, by synthesising the ethyl 
acetoacetate from ethyl [2-13C]acetate, generated from 
sodium [2-13C]acetate31, and [1-13C]acetyl chloride. 
Intially, the synthesis of racemic NAC thioester of 
3-hydroxy-2-methylbutanoic acid intermediate (170), was 
based on the general selective procedure by Masamune55, 
shown in scheme 3.5. The first step in this synthesis was 
methylation of racemic ethyl '3-hydroxybutyrate using 
Seebach's method49 to generate ethyl 
3-hydroxy-2-methylbutyrate, (163), which was then hydrolysed 
to the free acid using base in aqueous methanol. However, 
this hydroxy acid proved to be very water soluble and 
continuous extraction of the aqueous phase into diethyl 
ether was required to obtain a reasonable yield. This is a 





optically active NAC thioester of 
(25,3S)-3hydroxy- methylbutanoic acid, ' (170), and 
racemisation of the product might occur during this 
prolonged extraction. Work on this route was continued to 
the final thioester, by reacting the hydroxy acid with 
N-acetylcysteamine, using diphenyl phosphorane (DPPA) (165) 
as the coupling agent 
58. The required thioester (170) was 
formed, but the 1H nmr spectrum revealed that the coupling 
agent had also reacted with the hydroxyl group on C-3, 
indicated by the presence of phenyl resonances. Thin layer 
chromatography revealed that this was predominately one 
compound and not a mixture of a by-product from the coupling 
agent and the desired thioester (170). An alternative 
approach, to a similar NAC thioester, le. N-acetylcysteamine 
thioester of (2R, 3R)-3hydroxy-2-methylpentanoate (171), was 
described recently44 and this was applied to the coupling of 
the NAC thioester to 'the sodium salt of the THP protected 
ethyl 3-hydroxy-2-methylbutyrate (167), to try to generate 
the desired thioester (170). The approach is shown in 
scheme 3.5, and was first tried using racemic ethyl 
3-hydroxybutyrate as the starting material. As in the 
previous synthesis, the first step was a methylation 
reaction on ethyl 3-hydroxybutyrate, using Seebach's 
method49, and then the hydroxy group on C-3 was protected as 
the THP ether before the ester group was hydrolysed using 
base. Coupling-to give the N-acetylcystamine thioester was 
achieved by activating the sodium salt of the acid (167) as 
the mixed anhydride using methyl chloroformate, followed by 
reaction with N-acetylcystamine, and then deprotection, 
using a catalytic amount of trifluoroacetic acid in 
76 
methanol. These mild reaction conditions ensured that the 
acid sensitve NAC thioester group was not lost during this 
reaction. This route did produce the desired thioester (170) 
in reasonable yield. Proof that this synthesis was 
sucessful came from 
lH 
nmr analysis and high resolution mass 
spectrometry which gave a molecular ion at 220 as expected. 
This route was subsequently used to generate the optically 
active form starting from ethyl (3S)-3-hydroxybutyrate, as 
detailed below. 
The optical purity of the thioester of 
(2S, 3S)-3-hydroxy-2-methylbutanoic acid (170), which is not 
a literature compound, was determined by 
lH 
nmr using a 
chiral solvating agent. These CSA agents are diamagnetic and 
are used to dissimarily perturb the nmr spectra of 
enantiomeric solutes. The CSA and the solute must have 
complementary functionality which permits their interaction 
le. in general, one is a hydrogen bond acceptor and the 
other is a hydrogen bond donor. The CSA used in this 
experiment was R-(-)-trifluoroanthryl ethanol (TFEA). This 
attractively interacts with the enantiomeric solute (the NAC 
thioester), resulting in different spacial enviroments for 
their nuclei. Non-equivalence increases with an increase in 
CSA concentration until the solute is completely solvated by 
the CSA. Non-equivalence arises under these circumstances 
only from spectral differences in the diastereomeric 
solvates, not from different degrees of association of the 
solute enantiomers with the CSA, since no diminution of 
non-equivalence is observed even at high CSA concentrations. 








Figure 3.2 A mechanism for the stereospecific methylation 
reaction. 
that the signals being compared truly represent the 
enantiomeric ratio. Strictly, areas under peaks should be 
compared in making the ee determinations. However, in 
practice, it is sufficient to compare peak heights of the 
diastereo t, 'opic resonances. To optimise conditions for 
determining the resonances where non-equivalence may be 
readily observed, an intial experiment on racemic material 
is used. This whole method for determining the enantiomeric 
purity of compounds is well reviewed by Pirkle and Hoover 
61, 
The first step in this chiral synthesis of (170) was a 
stereospecfic baker's yeast reduction48 of ethyl 
acetoacetate. This reaction was carried out intially using 
fresh baker's yeast (Saccharomyces cere/isiae). , 
It was 
subsequently repeated using DCL active dried yeast (single 
strain, Saccharomyces cerevisiae). Both proceedures 
produced ethyl (3S)-3-hydroxybutyrate in a'yield of 48-50%. 
The optical purity of the products were measured by 
determining its optical rotation and comparing these to the 
literature value48(a) of +38.5. ,( ]D20 - +36.5° for fresh 
yeast reaction product (% optical purity - 95%), and (a)D20 
_ +36.1° for the dried yeast product (% optical purity - 
94%), Ethyl (3S)-3-hydroxybutyrate (162) was then 
stereospecifically methylated46'49. In this reaction, this 
lithium base blocks the top face of (162) by complexing 
between the hydroxyl group and the ester carbonyl, so 
forcing methylation to occur on the lower face (figure 3.2), 
giving (163) in a yield of 66%. The optical purity of the 
ethyl (2S, 3S)-3-hydroxy-2-methylbutyrate (163) produced was 
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literature value49(b) for this compound (163), [a]D22 = 
+19.1°. For the product from methylation of the alcohol 
generated from the fresh yeast reduction, [a]D20 = 20.4°, 
giving an optical purity of 94%. For the methylated product 
using the alcohol generated from the dried yeast reduction, 
(%'D20 = 22.7°, giving an optical purity of 84%. For 
conversion to the NAC thioester, the hydroxyl group was 
protected as a THP ether and then an analogous sequence of 
Steps to that outlined previously4'6 of the racemic thioester 
(170) was followed, ie. activation as a mixed anhydride 
(168), coupling to N-acetylcysteamine and finally 
deprotection. Purification of the resulting NAC thioester 
(170) was again achieved by flash chromatography. 
For incorporation studies, this chain assembly intermediate, 
(2S, 3S)-3-hydroxy-2-methylbutanoic acid was synthesised as 
the ethyl ester, NAC ester and sodium salt, with a deuterium 
label in the C-2 methyl group. This label was introduced 
from CD31 in the stereospecific methylation reaction. The 
1H 
nmr of. this optically active thioester is shown in 
figure 3.3. and shows that in the deuterium labelled 
material, the methyl of the butane chain signal appears as a 
doublet centered at 60.98, cf. in the unlabelled material 
two doublet signals are observed for the C-2 methyl group 
and the methyl group of the butane chain. The enantiomeric 
purity of this product was checked by 
lH 
nmr methods using 
(R)-(-)-TFEA as the CSA. In this experiment a 10: 1 addition 
of CSA to solute was used. For this NAC thioester (170), 
non-equivalence is readily observed in the amide methyl 
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as two singlet signals centered at 51.49 and in the chiral 
material, -this signal appears as one. singlet. at 61.53. This 
indicates this -material to be enantiomerically pure. Also, 
since there is only one doublet, signal for the. methyl-of the 
butane chain further supports,: that- no undesired 
epimerisation of the C-2 and C-3. L chiral. centres had 
occurred., - .. 'ý"I -11 
The- synthesis of - the NAC thioester., of 
(2E, 4S, 5S)-5-hydroxy-4-methylhex-2-enoic, acid (179) is shown 
in scheme 3.6. Again, racemic starting material,.. ethyl 
3-hydroxybutyrate (162) was used intially, to test this 
route. The first two steps, were as described in the 
previous synthesis of the NAC-"thioester deriviative of 
3-hydroxy-2-methylbutanoic acid (170). 'Various forms, of 
protection of the hydroxyl group on C-3, were, tried, to find 
one that could be readily cleaved using very mild reaction 
conditions, but which would remain intact throughout the 
synthesis. The groups tried were; trimethyl silyl- ether, 
tbutyl-dimethyl-silyl. ether, 0-(1-ethyoxyethyl).,, and finally 
THP ether. The only protecting group, of these tried that 
remained in place throughout the synthesis was theTHP 
ether. Both silyl ethers failed, to survive the reaction 
conditions of the lithium aluminium hydride. reduction,, and 
the-0-(ethoxyethyl) protection from ethyl vinyl ether did 
prove to be more resilient but was readily removed when the 
ester group was-hydrolysed. 
Treatment of the THP ether protected ethyl' 
3-hydroxy-2-methylbutyrate (166) with lithium, aluminium 
80 
hydride produced the alcohol (172) in very good yield. This 
was then oxidised to the corresponding aldehyde (173). This 
oxidation reaction proved to be difficult as the alcohol 
(172) was resisent to both pyridinium dichromate (PDC) and 
pyridinium chlorochromate (PCC) oxidation conditions. Swern 
oxidation 
11(e), 
using oxalyl chloride and dimethyl 
sulphoxide (DMSO) eventually provided the desired aldehyde 
(173). This was then subjected to a Wittig reaction56 with 
triphenyl-carbethoxymethylidene phosphorane to generate the 
unsaturated ester (174). The yield from this reaction was 
intially, poor, but changing the solvent from benzene to 
dichloromethane and increasing the reaction time to four 
days at reflux, did provide (174) in reasonable yield. 
Intially, the previous NAC thioester coupling reactions46 
were tried, `ie. -hydrolysis of the ester (174) to the free 
acid'(175), and then. activation as the mixed anhydride (176) 
- both reactions went in good yield - and then coupling to 
N-acetylcysteamine. The 1H nmr spectrum of the reaction 
product, revealed that the vinyl signals at 66.1-6.2 and 
66-. 9-7.0 were very weak. This indicated that the sulphur of 
the N-acetylcysteamine group, which is a 'soft' nucleophile, 
had attacked the carbon carbon double bond in a Michael type 
reaction. This is the 'soft' electrophilic site in this 
molecule and so this reaction should have been predicted. 
Some of the desired thioester (179) was isolated from. the 
reaction products by preparative tic. This problem of the 
Michael reaction was solved by changing the nucleophilicity 
of the sulphur. Instead of using N-acetylcysteamine, the 
Thallium (I) salt of N-acetylcysteamine was used50155,571 
and the coupling agent was changed to chlorodiphenyl 
81 
phosphinite. The sulphur now carries a full negative 
charge, and so is a much 'harder' electrophile and so 
attacks the 'hard' nucleophilic carbonyl site in preference 
to the 'soft' electrophilic carbon to carbon double bond. 
After deprotection using trifluoroacetic acid in methanol, 
and purification by flash chromatography pure NAC thioester 
(179) was formed. Nmr analysis was obtained for each 
intermediate compound, with the spectra being complex due to 
the presence of the THP ether protecting group. Figure 3.4 
shows the 300MHz nmr spectrum of this thioester (179). It 
clearly shows the thioester groups at 83.1 and 53.4, and 
vinyl resonances at 66.1-6.2 and 66.9-7.0, with J-15Hz for a 
trans double bond. The resonance for H-2 at 56.05 shows a 
very small splitting (1Hz) due to long range coupling to H-3 
which is four bonds away. This is not uncommon, especially 
since one of the intervening bonds is a "a bond. Mass 
spectrometry shows a molecular ion at 246 as expected. 
This NAC thioester (179), could now be synthesised in 
optically active form using this route, with ethyl (3S) 
3-hydroxybutyrate as the starting material. For 
incorporation studies, this NAC thioester could be 
synthesised in labelled form, with methylation using 
deuterated methyl iodide or with a 
13C label in the 
triphenyl carbethoxymethylidene phosphorane as being 
possible ways of introducing the required isotopic label, 
and the diastereomeric purity of this intermediate, could be 
































































55.28 MHz 2H nmr spectra of methyl pseudomonate isolated 
from incorporation studies using 
2H-labelled 
precursors. 
PRECURSOR S (ppm) ASSIGNMENT 
Sodium acetate 1.11 14-Methyl 
1.24 9-Hydroxynonanoic acid 
1.54 side chain resonances 
2.14 15-Methyl 
2H20 0.86 17-Methyl 
1.22 14-Methyl and 9-hydroxy- 
1.53 nonanoic acid side chain 
resonances 
2.19 15-Methyl 





1.09 Breakdown product 
1.1 
1.31 Breakdown product 
1.79 
1.12 
1.34 Breakdown product 
3.2 
3.4 INCORPORATION STUDIES ON CHAIN-ELONGATION ASSEMBLY 
INTERMEDIATES, IN P. fluorescens 
The proposed involvement of (2S, 3S)-3-hydroxybutanoic acid 
(170) as a chain assembly intermediate in the biosynthetic 
pathway to pseudomonic acid has been tested. This proposed 
intermediate was fed in three forms le. as the NAC 
thi"oester, as the ethyl ester and as' -the sodium salt. 
Deuterium at the C-2 methyl was the isotopic label 'us'ed and 
2H 
nmr spectroscopy was used to determine whether this 
precuror was incorporated intact. 
For comparison, an intial experiment to obtain a generally 
deuterated sample of methyl pseudomonate was . carried out. 
This was achieved by growing the culture*in'a'second stage 
medium containing 5% 
2H20. The 2H nmr spectrum of the 
isolated labelled methyl pseudomonate is shown in figure 
3.5, and assignment (table 3.1) was made by comparison with 
the lH nmr spectrum' of the metabolite. Sodium 
[2-2H3]acetate was also fed to the culture to provide the 
2H 
nmr spectrum shown in' figure 3. '6, -and the assignment is 
detailed in table 3.1. ' This was used to assess the level of 
intact incorporation of the' chain assembly intermediates 
labelled with deuterium, since breakdown to acetyl CoA then 
subsequent re-incorporation is the most likely route for 
label to enter the metabolite from catabolism of the 
precursor. 
- r. 
The results ' of feeding. 
(2S, 3S)[2'-2H3]-3-hydroxy-2-methylbutanoic acid in the three 
forms, specified above, to P. fluorescens and analysis by 
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2H 
nmr spectroscopy (table "3.1) revealed that: none of these 
compounds, were -incorporated intact. Catabolism of 
precursors larger than acetate or propionate has been an 
inherent problem with whole cell studies of polyketide 
metabolism59. It was thought, that precursors as their NAC 
thioester deriviatives could more easily undergo 
transesterification with the thiol group on an enzyme than 
an oxy ester60, but this compound (170) does not seem to 
have survived the fermentation conditions. 
3.5 CONCLUSIONS AND FURTHER WORK 
These synthetic approaches to the NAC thioesters of the 
proposed chain elongation intermediates to pseudomonic acid 
are suitable for the convenient introduction of isotopic 
labels, at the positions indicated in the text. These NAC 
thioesters could also be used to test other biosynthetic 
pathways. The incorporation of the NAC . thioesters of 
[2,3-13C2]acetoacetate and 
(2E, 4S, 5S)[4'-2H3]-5-hydroxy-4-methylhex-2-enoic acid remain 
to be studied, along with the corresponding oxy esters and 
sodium salts of these compounds. The diastereomeric purity 
of the latter compound (179), formed by the route detailed 
in scheme (3.6) remains to be checked. The intial results 
from incorporation of the NAC thioester of (2S, 3S) 
(2'-2H3]-3-hydroxy-2-methylbutanoic acid and the 
corresponding ethyl ester and sodium salt compounds have 
indicated that this whole cell system might not be suitable 
for testing this stepwise chain assembly to the final 
polyketide metabolite since none of these compounds were 
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incorporated intact. Further work to optimise the feeding 













General experimental details are as detailed on page 45. 
SYNTHESIS OF CYCLOHEXANE THIOESTER OF ACETOACETATE 
Meldrum's acid, (2,2-dimethyl-1,3-dioxane-4,6-diione), (159) 
(0.5g, °3.5mmol) in 25mlaof. dry dichloromethane was reacted 
with, acetyl chloride (0.33g, 0.3m1,, 4.2mmol)_and, pyridine, 
(0.54g, 0.55m1,6.8mmol), under a N2 atmosphere. - This 
solution was kept at 0°C for lh and then allowed to warm to 
room temperature and was stirred for a further . lh. After 
this time, the solution was washed with dilute HC1, water 
and. dried. over anhydrous MgSO4. The solvent was evaporated 
in vacuo to yield the acyl deriviative of Meldrum's acid 
(160) in a yield of 0.28g (1.5mmol, 43%). 
SH (CDC13,60MHz) 1.8 (6H, s, 2xCH3) , 2.1 and ". 2.25 -, (3H, 
2xs, tautomeric. signals for CH3-C-C-CO), 
2.7 (1H, s,. OH) . LL 
This acylated Meldrum's"acid (160), (0.28g, 1.5mmol), was 
reacted with- cyclohexane"thiol (0.42g, 0.44ml, 3.6mmol, 2.4 
equiv. ),,. under a N2. atmosphere, in refluxing dry benzene for 
3h. The resulting solution was cooled and the benzene 
evaporated in vacuo. The product was purified by 
preparative tlc using 3% ether, -in petrol ether (30-40°) as 
the running solvent. This, yielded the cyclohexane thioester 
of acetoacetate (161) as an orange oil (0.12g, 0.60mmol, 
40%). - 
8H (CDC13,60MHz) 1.2-2.2 (10H, br, CH2 ring protons), 2.3 
86 
u 
(3H, s, CH3CO), 2.6-3 (br, 'OH), 3.7 (2H, 
s, CH2CO), 5.4 (olefinic proton). 
SYNTHESIS OF THE N-ACETYLCYSTEAMINE "THIOESTER OF, 
ACETOACETATE 
nButyl lithium (13.9ml of a i. 6M solution in hexanes, 2.1 
equivalents) was added to a stirred solution of HMDS (5m1, 
23.5mmol, 2.1 equivalents) in dry-THF (5ml) at"-780C, under 
a nitrogen atmosphere. After being stirred-for 5min at 
=78°C, the solvents were removed in vacuo at room 
temperature. The resulting white solid, was re-dissolved in 
° dry THF-°(30ml) and cooled to -78C, under a nitrogen, 
atmosphere. Ethyl acetate(lg, 12.7mmol) was added'slowly 
to' the reaction mixture and this was then stirred for a 
further 20min. -Acetyl chloride (1.1ml), as-a solution in 
iml of dry THF, was added slowly, --to the generated. °enolate 
and-the mixture stirred for 15min`at -78°C. 2M HC1 
(15ml) was 'added and the aqueous and organic layers were 
separated, and the' aqueous layer- further extracted, with 
diethyl ether (3x 20ml). Organic extracts were combined, 
dried over, anhydrous MgSO4*and evaporated°to dryness. This 
yielded ethyl acetoacetate (151), 1.55g (11.9mmol, -94%) 
8H (CDC13,250.133 MHz) 1.3 (3H, t Ja4.8Hz, CH l. -9 ' (CH 
of enol -form) , 2.3 (3H, 's, CH3CO) , 
3.45 (2H,, s, CH2CO), 4.2 (2H, q 
Ja7.2Hz, OCH2)', 5.0 (olefinic CH). 
Ethyl - acetoacetate (151), (log, - 9.7ml, 77mmol) was ; reacted 
with-(9.9g, 154mmol, 2 equivalents) of . 'ethylene glycol--in 
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the presence of a catalytic amount of toluene-4-sulphonic 
acid (PTSA) in'dry benzene (70m1), for 24h at reflux using °a 
Dean-Stark apparatus. After cooling the solution, it was 
washed successively with; 5% NaHCO3 solution (50m1), water 
(2x'50m1)'and then dried over anhydrous-MgSO4'; The solvent 
was evaporated in vacuo'to yield'ethyl acetoacetate ethylene 
ketal . x(152) as 'a yellow, oil,, (10 . lg, ' 
58mmol; , 75% ) 
6H (CDC13,60MHz) 1.2 (3H, t J=7Hz, CH3), 1.45 (3H, s, CH3)1 
2.65 (2H, s, CH2CO), 'overlapping signals 
at 3.95 (4H, s, 2xCH2O) and 4.15 (2H, -, q 
Ja7Hz, OCH2) 
The protected ester (152), (1g, 5.7mmol) was-stirred at room 
temperature in a'solution of KOH (1.44g, 4.5 equivalents) in 
water/ethanol (15m1 of a 1/1, v/v mixture). The solvent was 
evaporated and water was added and this aqueous solution was 
then extracted into hexane (3x 20m1). The hexane extracts 
were combined . and back extracted with water. All the 
aqueous extracts were combined and the pH adjusted to, 8 with 
1M HC1 before the water was-: removed as an ethanol azeotrope 
to yield a -white solid. - 
The resultant sodium acetoacetate ethylene ketal'(153) was 
used directly in the next reaction. This white solid was 
suspended in dry THE (20m1)' and methyl chloroformate 
(0.86m1,12.5mmol, 2.2 equivalents) and one drop of 
triethylamine were added. The resulting suspension was, 
stirred vigorously at room temperature for 24h. Celite was 
added and the mixture was filtered and the filtrate 
concentrated in vacuo to yield the mixed anhydride of methyl 
formate acetoacetate ethylene ketal (154), (0.97g, 4.75mmol, 
88 
83%). 
SH (CDC13,60MHz) 1.5 (3H, s CH3), 2.8. (2H; s, CH2CO), 3.9 
(3H, s, OCH3), 4.0 (4H, s, -2xCH2O). 
ETHANETHIOIC ` ACID (S)-[2-(ACETYLAMINO)ETHYLIESTER 
(N, S-DIACETYLCYSTEAMINE) (156), AND 
N-(2-MERCAPTOETHYL)ACETAMIDE (N-ACETYLCYSTEAMINE (157)'' 
To a three-necked-, 250m1 round bottomed flask equipped with a 
pH electrode and two addition funnels "was added 5.68g 
(50mmol) of 2-mercaptoethylamine hydrochloride in 40ml of 
water. One addition 'funnel was` filled with 14.14ml 
(150mmol) of acetic anhydride and the other with ca. 40ml of 
8M KOH. After- the contents of the-flask had been cooled by 
means of an ice bath and the pH had been adjusted-to 8.0 (by 
addition of some of the KOH solution), acetic anhydride was 
added dropwise along with sufficient KOH solution to 
maintain the pH at approximately 8.0. After, 'all the acetic 
anhydride had-been added, the pH of the reaction mixture was 
adjusted to 7.0 by addition of 2M HC1-solution, and the 
mixture was stirred for ih. NaCl was then added until the 
solution was saturated and this mixture was extracted with 
dichloromethane (5x 50m1). The combined extracts were dried 
and concentrated to yield 8. Og (98%) of a colourless oil, 
(156). 
SH (CDC13,60MHz) 2.0 (3H, s, CH3CONH), 22. "4 (3H, s, CH3COS), 
2.9-3.2 (2H, m, CH2S), 3.3-3.6 (2H, m, 
CH2NH), 6.8 (1H, br s, NH). 
Compound (157), was generated as follows; To a 250m1 round 
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bottomed flask -containing 3.06g (19mmol);: of"'-_ 
N, S-diacetylcysteamine in water (100ml), cooledlto 100C, was 
added solid KOH (3.55g, 63.3mmol). This solution was 
stirred at room temperature, for 0.5h, under. a nitrogen 
atmosphere. After adjusting the pH to 7( with iM HC1) and 
saturating -the -solution with NaCl, it- was extracted with 
dichloromethane (5x 50ml). The-, combined organic extracts 
were dried, and evaporated to yield a. colourless oil, (157) 
which was used immediately in the following reaction. 
aH (CDC13,60MHz) 1.45 (1H, t J-7Hz, SH), 2.0 (3H, s, 
CH3CO), 2.45-2.9 (2H, m, CH2SH), 3.2-3.6 
(2H, m, CH2NH), 7.0 (1H, br s, NH). 
The mixed anhydride (154), (0.97g, 4.75mmol)" was reacted 
with -; N-acetylcysteamine (157), (1.31g, 11. lmmol, 
" 2.4equivalents) in dry THE (20ml) and triethylamine (1.4m1, 
9.5mmol, 2 equivalents),. - This solution was stirred at room 
temperature for 24h. Ethyl acetate was added, and the 
solution washed with cold iM KOH. The aqueous extract was 
back extracted with some more ethyl acetate-and the organic 
extracts were combined, dried and evaporated in vacuo to 
" 
yield the N-acetylcysteamine thioester of acetoacetate 
ethylene-ketal (155) as a thick yellow, oil. (1.03g, 4.2mmol, 
88%). 
6H (CDC13,60MHz) 1.4 (3H, s, CH3), 2.0'(3H, s, CH3CO), 2.95 
. (2H, s, CH2CO) and this signal overlaps 
with 3.0-3.3 (2H, m, CH2S) , 3.4-3.7. (2H, 




The protected thioester (155), (0.5g, 2mmol) was reacted 
with toluene-4-sulphonic acid (0.42g, 2.2 mmol, 1.1 
equivalents) in dry acetone (10ml) at'reflux for 2.5h. This 
yielded NAC thioester of acetoacetate (144), 0.247g 
(1.2mmol, 60%) as an oil which was purified by flash silica 
column chromatography using 100ml of hexane/ethyl"acetate 
(1/4) and 1 drop"of triethylamine and then 100ml of 100% 
ethyl acetate' and 1 drop of triethylamine. This provided 
pure thioester (144) as a yellow oil (0.288,1.4mmol, 70%). 
SH (CDC13,80.13MHz) 1.8. (three overlapping s, CH3, enol 
form of the'b-ketone and amide), 2.1 
(6H, s, 2xCH3CO), 2.9 (2H, m, 'CH2S), 
3.3 (2H, m, CH2NH), 3.6 (2H, s, CH2CO), 
5.3 (olefinic CH), 6.2 (br s, NH). 
Mass spectrum m/z 204 (M+) 
Calcca. for' C8H140o3S (rv ) 204"06443; -fuu»d a04. "0617cto , 
SYNTHESIS OF THE N-ACETYLCYSTEAMINE THIOESTER OF, 
(2S, 3S)-3-HYDRORY-2-METHYLBUTANOIC ACID 
Fresh baker's yeast (100g) was dispersed into a solution of 
sucrose (1000g) in 8000ml of tap water contained in a 
fermentor. After 0.5h the yeast-was activated and ethyl 
acetoacetate (22.1g, 21.5ml, 0.17mol) was-added in portions 
over a 8h period. This suspension was then allowed to stir, 
with aeration at a temperature of 28°C- for 4 days. The 
cells were removed by centrifugation and the aqueous phase 
extracted with diethyl ether (81), dried over anhydrous 
MgSO4 and evaporated in vacuo. After distillation under 
reduced pressure (450C, 0.7mbar), ethyl 
(3S)-3-hydroxybutyrate (162) as a colourless oil was 
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obtained (8.23g, 0.063mo1,, 37%). 
aH (d6 benzene, 200.130MHz) 0.9 (3H, t J-5Hz, CH3), 1.0 (3H, 
d J-5Hz, CH3), 2.1-2.18 (2H, m, 
AB of an ABX, CH2), 3.9 (1H, br 
s, OH), 3.8 (2H, q J=5Hz, OCH2), 
4-4.1 (1H, m, X of an ABX, H-3). 
Calculation of specific rotation: 
Weight of compound used a 0.157g in 5ml CHC13 
Readings = 1.146,1.146,1.145 
Average = 1.146 
Temperature = 20°C 
Specific rotation -observed rotation (degrees) 
length (dm) x g/cm3 
= 1.146 
1'x 0.0314 
- +36.5° - 41 " 
Lit48(a) [a D 
20 
. +38.5° (CHCU3; C 1), 
The yeast reduction was repeated using 5x 500ml shake'flasks 
and active dried yeast (single strain, Saccharomyces 
cerevisiae). Each flask contained yeast (log) and glucose 
(log) in 100ml of distilled water. Fermentation and feeding 
conditions (le. 1g, l. lml ethyl acetoacetate per flask) were 
as for the' fresh yeast. The cells were removed by 
filtration through celite. The resulting aqueous extract 
was extracted into diethyl ether (5x 100ml), 'dried over 
anhydrous MgSO4 and the solvent evaporated in vacuo. After 
distillation under reduced pressure, as above, 
ethyl- (3S)-3-hydroxybutyrate (162), as a colourless oil was 
obtained, (3.26g, 24. lmmol, 64%). 
SH (CDC13,300.133MHz) 1.24 (3H, t J-6Hz, CH3), 1.34 (3H, t 
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J-6Hz, CH3), 2.45 (2H, m, AB of ABX, 
CH2), 4.1-4.25 (2H, q J-6Hz, OCH2), 
overlaps with (1H, m, X of ABX, H-3). 
Calculation of specific rotation: - 
Weight of compound used = 0.134g in 10ml CHC13 
Readings = 0.484,0.483,0.484 
Average - 0.484 
Temperature = 20 °C 
[a]D20 a +36.1° 
To a stirred-solution.: of-di-isopropylainine (10.9m1,77mmol) 
in dry THF, under'a N2 atmosphere at -780C was added 
nbutyl 
lithium (46m1 1.4M solution in hexanes). The resulting 
solution was allowed to warm to 0°C and then re-cooled to 
-50°C and ethyl (S)-3-hydroxybutyrate (4m1,29.8mmol) was 
added quickly. After the addition was complete, the 
solution was allowed to warm slowly to -20°C and then was 
re-cooled to--780C. - Methyl iodide (8m1,128mmol) in dry THE 
(5m1) was added and the resulting solution allowed to warm 
to room temperature and was stirred at' room temperature 
overnight. Saturated NH4Cl solution (10ml) was added' and 
the THE evaporated. The residue was extracted into diethyl 
ether (5x 50m1), 'and these organic extracts were combined 
washed with brine, dried over` anhydrous MgS04` -'and 
concentrated in vacuo. The resulting brown oil was purified 
by''Kugelrohr distillation (400C, 0.07mbar). This yielded 
ethyl (2S, 3S)-3-hydroxy-2-methylbutyrate (163), ° as a 
colourless oil'7(2.53g, 66%). 
SH (CDC13,300.133MHz) 0.9 (3H, t J-6Hz, CH3)1 1.0 (3H, d 
3-6Hz, 'CH3); 1.05 (3H, d J-6Hz, CH3)1 
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2.3 (1H, dq Ja6Hz, H-2), 3.75 (1H, dq 
J=6Hz, -H-3), 3.9 (2H, q J-6Hz, OCH2). 
Calculation of specific rotation: 
Weight of compound used = 0.300g in 10ml CHC13-' 
Readings = 0.613,0.622,0.611 
Temperature = 200C 
I :t, 
ýaýD20 - +20.40 
Lit. 49(b) [«]D +19.1° (CHC13, c 1.3) 
The ethyl (2S, 3S)-3-hydroxy-2-methylbutyrate generated from 
using the dried baker's yeast gave the following optical 
rotation: 
Weight of compound used = 0.0608g in'10ml CHC13 
Readings = 0.138,0.138,0.139 




To ethyl (2S, 3S)-3-hydroxy-2-methylbutanoate (163), (1.51g, 
10.3mmol) in dichloromethane at 0°C, was added dihydropyram 
(4.6m1,4.4g, -52.5mmol, -, 5equiv. ) followed by trifluoroacetic 
acid (1- drop). This solution was stirred at room 
temperature overnight. Volatile materials were evaporated 
to yield the, tetrahydropyran ether (165) in quantitative 
yield, (2.46g). - this was used directly without' -f 
purification. To a solution : of (165), (2.43g, 10.4mmol) in 
dry methanol (20m1), cooled to 0°C was added 2M, NaOH-, (7.6m1, 
15.15mmol, 1.5equiv)". This was stirred at room temperature 
overnight. The methanol was evaporated and distilled water 
(20m1) was added to the residue which was extracted with 
hexane "(3x20m1). The hexane extracts-were, combined: andback 
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extracted with' water. All the aqueous extracts were' 
combined and the pH adjusted to 8 with 1M HC1. The water 
was removed as an ethanol azeoptrope to yield the'sodium 
salt of the' THP ether of 3-hydroxy-2-methylbutyrate (167) as 
white solid. This was used directly in the next stage of 
the reaction. This white solid was suspended in dry THE 
(35m1) and methyl chloroformate (2.3m1,16.3mmol, 2.2 
equiv. ) and triethylamine (1 drop) was 'added. This 
suspension was stirred vigorously at room temperature for 
24h. Celite was added and the mixture filtered. - The 
filtrate was concentrated in vacuo to yield the mixed 
anhydride (168), (2.36g, 9. lmmol', 88%). '- 
8H (CDC13,80MHz) Inter 'alia, (two-1H, -m, ace'tal'protons), 
3.8 (3H, br s, OCH3). 
To the crude mixed anhydride (168), (2.355g, 9mmol) as a 
solution in dry THF, cooled to 00C, was added 
N-acetylcysteamine (2.3g, 27mmol, 3 equiv. )", generated as 
described previously, and triethylamine (7.6m1, l8mmol, 2 
equiv. ). ' 'This'mixture was stirred at room temperature for 
20h. It was then diluted with ethyl acetate (100ml)'and 
washed with cold 1M KOH (2x40m1). The'aqueous extract was 
back extracted with ethyl acetate. Organic extracts were 
combined, dried and evaporated-to yield the protected NAC 
thioester of 3-hydroxy-2-methylbutanoic acid (169), (2.41g, 
7.8mmol, 86%). Deprotection of (169) to yield NAC thioester 
(2S, 3S)-3hydroxy-=methylbutanoic acid _(148) was' achieved by, 
reacting (147)'(2.4g, 7.84mmol) with a catalytic amount of 
trifluoroacetic acid (0.04m1) in methanol (20m1). The 
solution was stirred'at room temperature for 16h and then 
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the volatile materials were evaporated in vacuo to yield 
(170) as a yellow oil (1.66g, 7.6mmol, 97%). This crude NAC 
thioester was purified by flash silica column 
chromatrography. The eluting solvents were; ethyl acetate: 
hexane (4/1), and 1 drop triethylamine (50m1) and then 100% 
ethyl acetate and 1 drop of triethylamine (200m1). This 
yielded pure NAC thioester (170) (1.29g, 5.9mmol, 76%). 
SH (CDC13,250.133MHz) 1.2 (3H, d J-7.1 Hz, CH3), 1.25 (3H, 
d J=6.3Hz, CH3), 1.98 (3H, s, CH3CO), 
2.65-2.75 (1H, m, H-2), 3.0-3.1 (2H, 
. m, 
CH2S), 3.4-3.5 (2H, dq J-7. lHz, 
CH2N, 3.9 (1H, dq J-6.5Hz, H-3), 5.9 
and 6.4 (2xbr s, OH, and NH). 
Mass'spectrum m/z 220 (M+), 45 (CO2), 60 
(CH3CONH2+), 119 (CH3CON(CH2)2S+). 
c. aýocl. r cý H i$ Nb3S 
AIM H+ý aao "i OO ii -f ouncl P, 20-/00'700 
SYNTHESIS OF THE NAC THIOESTER OF 
(2S, 3S)-[2'-2H3]-3HYDROXY-2-METHYLBUTANOIC ACID 
This compound was prepared as described, for the synthesis 
of (170), starting from ethyl (2S)-3-hydroxybutyrate (162), 
(3.5m1,26.1mmol) formed by yeast reduction of ethyl 
acetoacetate, and alkylating (162) with CD31, (8m1,128mmol, 
99.5+ atom % D) to give ethyl 
(2S, 3S)-[2'-2H3]-3-hydroxy-2-methylbutyrate (163), (2.531g, 
66%). The 1H nmr spectrum showed the signal at 62.65 for 
H-2 as a broad doublet, and the absence of a doublet for the 
c-2 methyl group', as it is labelled with deuterium. The rest 
of this spectrum was as in the unlabelled material. Ethyl 
(2S, 3S)-[2'-2H31-3hydroxy-2methylbutyrate (163), (1.51g, 
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10.34mmol), was then converted to the corresponding NAC 
thioester (170), as outlined previously, in a yield of 1.29g 
(5.9mmol, 76%). All the H nmr spectra of the intermediate 
compounds with the THP ether group were complex and complete 
spectral data is given for the final NAC thioester (170). 
6H (CDC13,250.133MHz) 1.25 (3H, d J-6.3Hz, CH3), 1.98 (3H, 
s, CH3CO), 2.3 (1H, br s, OH), 2.65 
(1H, br d J-7.5Hz, H-2), 3.0-3.1 (2H, 
m, CH2S), 3.4-3.6 (2H, m, CH2N), 
3.9-4.0 (1H, dq J-6.5 Hz, H-3), 5.9 
(1H, br, NH). 
SODIUM (2S, 3S)-[2'-2H3]-3-HYDROXY-2-METHYLBUTANOIC ACID 
Hydrolysis of labelled (163), (0.5g, 3.4mmol) to (164) was 
achieved using an automatic titrating apparatus. The 
starting pH was 12.0 and was maintained during the 
hydrolysis of the ester group by automatic addition of l. OM 
NaOH solution, over a 24h period. This aqueous solution was 
then washed with hexane (3x 20ml). Hexane extracts were 
combined and back extracted with water. All aqueous 
extracts were combined and freeze-dried to yield (164), 
(0.42g, 3.39mmol). 
SH (CDC13,250.133MHz) 1.1 (3H, d J-6.4Hz, CH3), 2.25 (1H, d 
J-7Hz, H-2), 3.95 (1H, dq J-6.5Hz, 
H-3). 
SYNTHESIS OF NAC THIOESTER OF RACEMIC 
5-HYDROXY-4-METHYLHEX-2-ENOIC ACID. 
The THP ether of ethyl 3-hydroxy-2-methylbutyrate (166), 
97 
(lg, 4.3mmol), in anhydrous diethyl ether (5m1) was added 
dropwise to a stirred suspension of LiA1H4'(0.1g1 mmol) in 
dry diethyl ether (15m1), under N2 atmosphere. The reaction 
was stirred at room temperature for lh and then refluxed for 
2h. After cooling, water (0.5ml), ý5% NaOH (0.5m1) and water 
(iml) were added in succession and the'resulting suspension 
was stirred for a few minutes, and then it was filtered 
through an anhydrous MgSO4 plug. The filtrate was 
concentrated in vacuo to yield the THP -ether of 
3-hydroxy-2-methylbutan-l-ol (172), (0.795g, 4.2mmol, 98%). 
8H (CDC13, "300.133MHz) Inter alia 0.95 (3H, '2xd J-6Hz, CH3), 
1.2 and 1.3 (3H, 2xd J-6Hz, CH 3 ), 2-. 8 
(br s, OH). 
To a" solution of dry -dichloromethane ('25ml) and oxalyl 
chloride (1. Oml, llmmol), cooled to -78°C was added dimethyl 
sulphoxide '(1.70m1, '22mmol) in dry dichloromethane (5ml). 
The resulting solution was stirred"for 2min and the alcohol 
(172), (1.57g, 8.4mmol) in dry dichloromethane (20ml) was 
added within 5min. ' The resulting solution was stirred for a 
further 15min at'-78°C. Triethylamine (7. Oml, 50mmol)was 
then added and the mixture then stirred for a further 5min 
at -78°C, before being allowed to warm slowly to room 
temperature. Water (50m1') 'was added and the layers 
separated. ' The- aqueous layer was re-extracted with 
dichloromethane"(50ml). Organic extracts were combined and 
washed with brine, dried and evaporated to a small volume. 
This: residue was 'taken up in some more dichloromethane and 
washed successively with 1% HC1, water, dilute (5%) NaHCO3 
. '98 
solution, water and then dried and evaporated to dryness. 
This yielded the THP ether of 2-hydroxy-3-methylbutan-l-al 
(173), (0.98g, 5.3mmol, 63%). 
6H (CDC13,300.133MHz) Inter alia 1.05 and 1.1 (3H, 2xd 
Ja6Hz, CH3)1 1.19 and 1.3 (3H, 2xd 
Ja6Hz, CH3), 2.45-2.6 (1H, in, H-2), 
4.0-4.1 (1H, in, H-3), 9.73,9.77 (1H, 
2xd J-3Hz, CHO) and 'minor 
-diastereoisomers at 9.78 and 9.81. '. 
Ethyl bromoacetate (13.3m1,20g, 0. `12mol) and ' 11 
triphenylphosphine (31.44g, 0.12mol) in toluene (100ml) were 
mixed and stirred at room temperature overnight. The 
resulting white precipitate was filtered and dried to yield 
ethoxycarbonylmethylenetriphenyl phosphonium bromide, 50.6g 
(0.12mol, 97%). 0 
Mp 156-159°C (lit. value56 ='1580C)' 
SH ' (CDC13,60MHz) 0.33' (3H, t, - J=8Hz, CH3) , 3. '31 ' (2H, q, 
J-8Hz, CH2), 4.78 (1H, bd, J-14Hz, CH), 
6.75-7.5 (15H, m; aromatic protons). 
This- salt, ethoxycarbonylmethylenetriphenyl phosphonium 
bromide, (1g, 2.51mmol) was dissolvedýin water (50m1) and 
titrated against 0.05M NaOH solution with vigorous stirring 
using phenolphthalein as an indicator. The resulting 
solution was extracted with dichloromethane (2x5Oml), dried 
and the solvent removed in vacuo to yield a white solid, 
ethoxycarbonylmethylene-triphenyl, phosphorane, 0.647g 
(2.04mmol, - 95%)'. i 
Mp-115-119°C (lit. value56 117°C). This-ylide can be 
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stored at-0°C indefinately 
6H (CDC13,60MHz) 0.84 (3H, t, J-8Hz, CH3), - 2.99-(2H, bs,, 
CH2), 3.74 (2H, q, -J-8Hz, OCH2), 6.75-7.5 
(15H, in, aromatic protons). 
e ý. ý 
To... the, aldehyde (173), (0.52g, 2.8mmol )' in, dry 
dichloromethane (50m1) was-added the ylide'. (3,. 5g, 11.1mmol, 
4equiv. ) and the solution ref luxed for 4 days under a N2 
atmosphere., After cooling, water (50ml) was added and the 
aqueous layer separated. The aqueous layer was re-extracted 
with-diethyl ether (50m1). The organic layers were - 
combined, -dried and evaporated. The residue was cooled in 
an ice bath and the ýtriphenyl phosphine oxide allowed to 
crystallize out. A small portion of diethyl-ether was added 
and the precipitated triphenyl phosphine oxide filtered off. 
After evaporation of the solvent, the residue was further 
purified by flash column chromatography using hexane: ethyl 
acetate ° 1/4 as the eluting solvent. This-, yielded the THP 
ether of-ethyl 3-hydroxy-2-methylhex-2-enoate (174), (0.69g, 
2.7mmol, 96%). 
6. (CDC13,300.133MHz) Inter alia, 1.1-1.3 (9H, m, 3xCH3), 
4.1-4.25 (2H, m,, OCH2), 5.8,5.85 and 
5.9 (1H, 3xm, H-2). - 
The protected unsaturated ester (174), -(0.69g, ' 2.7mmol), 'was 
hydrolysed to the- corresponding sodium salt (175) by 
" reaction with 2M NaOH (1.7m1,1.5equiv. ) in methanol (10ml). 
The aqueous solution was stirred at room temperature for 
20h. The methanol was evaporated and water (20m1) was 
100 
added: -- This was extracted with hexane (3x20m1)Y The hexane 
extracts were combined and back extracted with water. The 
aqueous extracts-were combined and the pH adjusted to-8 with 
1M HCl solution. - The-water was removed 'as an ethanol 
azeotrope, to yield as a white solid, the sodium salt of the 
THP ether of 5-hydroxy-4-methylhex-2-enoic acid (175)'which 
was used directly in the next-reaction. 'The white solid 
(175), _-was- reacted with triethylamine (0.38ml, 0.27g, 
2.7mmol) and chloro diphenyl phosphinite i(0.56m1,0: 73g, ' 
2.7mmol) in dry dichloromethane, at -78°C under N2 
atmosphere, for 15min. After warming to room temperature 
the solution was stirred for a further 10min and then was 
diluted with diethyl ether and the amine hydrochloride 
by-product removed by filtration. The filtrate was washed 
with bicarbonate solution, dried and evaporated to produce 
an oil, the mixed-phosphate anhydride (177). Again this was 
used directly in the next reaction. 
SYNTHESIS OF THALLIUM (I) SALT OF 
N-(-2-MERCAPTOETHYL)ACETAMIDE. '.: 
This was prepared as described by Schwab and Klassen. To. a 
dry, pre-weighed 250m1 round bottomed flask equipped'with"a 
magnetic stirring bar and a rubber septum cap was added 
3.72g (14.9mmol) of Thallium ethoxide. -Following the 
addition to the flask of 145m1 of nitrogen saturated THF, 
1.86g (15.65mmol) of freshly-prepared N-acetylcysteamine was 
added dropwise, via syringe, over a period of 20min. The 
concentration of T1-NAC in the' resulting bright yellow 
suspension (which was stored at 4°c) was calculated to be 
101 
0.098M. 
The mixed phosphate anhydride (177), generated above, was 
taken up in dry degassed THE (70m1), under a N2 atmosphere 
and *cool'ed to '0°C and 'Thallium (I) ° N-acetylcysteamine 
(27.5m1,2.7mmol)was added to this solution. The resulting 
yellow suspension was stirred at 0°C for-4h and then at room 
temperature overnight. The solution had changed colour from 
yellow to white during this time. The reaction mixture was 
concentrated in vacuo and the -residue taken. up'"in. diethyl 
ether and' filtered' through -: celite. ' The filtrate was 
concentrated to yield the THP ether of NAC thioester of 
racemic 5-hydroxy-4-methylhex-2-enoic acid (178). -=The THP 
ether "protection on (178) was removed by stirring in 
methanol (5m1) with 1 drop of trifluoroacetic acid, it room 
temperature overnight. " The volatile materials were 
evaporated off and the residue taken up in ethyl acetate and 
washed with 5%-NaHCO3 solution and then dried and evaporated 
to dryness to yield the crude product (179), (0.25g, 
1.02mmol, 38%, based on the amount of starting unsaturated 
ester). This was purified by preparative' tic using 
hexane: ethyl acetate 1/5 and 1 drop of triethylamine as the 
eluting solvent. This yielded 110mg of pure NAC thioester 
of 5-hydroxy-4-methylhex-2-enoic acid (179). - 
a H` 
(CDC13,300.133MHz )' 1.1 (3H, d 'J-6Hz, CH3) 1' 1.2 -(. 3H, '-d 
J-6Hz, CH3), 1.9 (3H, s, CH3CO), 
2.3-2.4 (1H, m, H-3), 3.05-3.1 (2H, 
m, SCH2), 3.4-3.45 (2H, m,,, CH2N), 
3.7-3.8 (1H, in, H-4) l 6.1-6.2(1H, dd 
Jvicinal°15Hz, Jallylic=1Hz, H-2), 
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, 6.6 (br s, exchangeable NH), 6.9-7.0 
(1H, dd J-15Hz, 7.5Hz, H-3). 
Mass spectrum m/z 246 (M+) 
Cäß -ý©; cj, NaoNa3s 
CmN{) a b-1163 ;. fcuncl A46, -1164 dc>o 
INCORPORATION STUDIES USING CHAIN-ELONGATION INTERMEDIATES 
In all these studies, the', modified culture and fermentation 
conditions were used. 
INCORPORATION 'OF `N-ACETYLCYSTEAMINE THIOESTER OF 
(2S, 3S)-[2'-2H3]-3HYDROXYBUTANOIC ACID 
In this incorporation experiment, ten second stage flasks 
were set up, as, outlined previously. After 20h: 
fermentation, the labelled precursor (500mg, as a-solution 
in 3m1 DMSO, le. 0.3ml/flask) was added to the growing, - 
culture. The flasks were harvested, -as detailed previously, 
after 40h fermentation and yielded methyl pseudomonate as a 
white solid (73mg). 
INCORPORATION OF ETHYL (2S, 3S)-[2'-2H3]-3-HYDROXYBUTYRATE 
Again, ten second stage flasks were used in , this feeding 
study. These were set-up as detailed previously, and the 
labelled precursor was again added to the growing second. 
stage culture after 20h, - (500mg, ° as -a' solution in sterile 
water (lml) le. 
0. lml/flask). After 40h fermentation, the flasks were 
harvested to yield methyl pseudomonate as a white solid, 
(61.3mg). . 
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INCORPORATION OF SODIUM (2S, 3S)-[2'-2H3]-3-HYDROXYBUTYRATE 
Again, ten second stage flasks were used in this feeding 
study. These were set up as detailed previously, and-this 
labelled precursor added to the fermentation after 20h, 
(210mg as a solution in 10ml sterile water, le. lml/flask). 
After, -4O h fermentation the flasks 'were harvested and after 
workup yielded methyl pseudomonate as a white solid, (60mg). 
INCORPORATION OF SODIUM [2-2H3]ACETATE 
(1) Ten second stage flasks were set up as detailed 
previously and - fed" with (2-2H31acetate after, 20h 
growth,, (250mg as a solution in sterile. water 10ml, le. 
iml/flask). These flasks were harvested after 40h 
fermentation. The pH of the culture supernatant was 
unusually low (pH 3.5). Extraction was carried out as 
described previously, except the pH of the supernatant 
was left unaltered. After workup, a colourless oil 
(20mg) was obtained which had a rf 0.3. This was shown 
by 1H nmr to methyl pseudomonate. 
(2) To take into account, the extra acidity of feeding 
(2-2H3]acetate, the second stage medium was buffered on 
the alkaline side, as detailed for the (1-13C]acetate 
incorporation experiments. In this incorporation study, 
twenty second stage flasks were used and inoculated as 
described previously. After 20h fermentation 
(2-2H3jacetate (200mg as a solution in 10ml sterile 
water, ie. 0.5ml/flask) was added to the growing 
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culture. These flasks were harvested after 40h 
fermentation and the pH of the culture supernatant was 
normal (pH 8). After workup as described previously, 
this yielded methyl pseudomonate as a white solid 
(130mg). 
GROWTH OF P. fluorescens IN A SECOND STAGE MEDIUM CONTAINING 
5% 2 H2O 
The second stage culture medium containing all, the 
constituents detailed previously was dissolved in 
2H20 
(50m1) and sterile water (950ml). This solution was 
dispensed into ten second stage flasks and autoclaved as 
detailed previously. These flasks were inoculated and grown 
up using the fermentation conditions outlined previously. 
They were harvested after 40h fermentation and yielded 
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Biosynthetic Studies on Pseudomonic Acid (Mupirocin), a Novel Antibiotic 
Metabolite of Pseudomonas fluorescens 
Fionna M. Martin and Thomas J. Simpson'"t 
Department of Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, Scotland 
2H and 180 Isotope shifts observed in the . 
13C n. m. r. spectra of pseudomonic acid (mupirocin) enriched 
from [1-13C, 2H, ]- and [1"C, 180, ]-acetates provide information on the mechanisms of formation of 
the tetrahydropyran and ester functions. The results of incorporation studies with 14C- and "C, - 
labelled ß-hydroxy-ß-methylglutarates do not support previous proposals for its involvement in the 
biosynthesis of pseudomonic acid. 
Pseudomonic acid A is a structurally unique antibiotic pro- 
duced by P. ctUJWHunrlc, /1euore. cceets1 and which is now being 
used clinically under the generic name mupirocin for topical 
treatment of skin infections. it has a complex structure (1) 
$ Preornt u h/recc: Department' of Chemistry, Unisersity of Leicester. 
University Road. Leicester LEI 7RH 
consisting of a C unsaturated carboxylic acid entity 
containing epoxide, diol, and tetrahydropyran functions. 
esterified by a 9-hydroxynonanoic acid entity. ' On the basis of 
preliminary biosynthetic studics3 the pathway summarised in 
Scheme I was proposed. According to this. pseudomonic acid is 
essentially pol)ketide in origin and is elaborated ria C12. C,, 
and C. units. Among the unusual features of the pathway are 
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Table. 2H and 1110 Isotope-induced shifts obser ved in the 90.56 MHz 
13C n. m. r. spectrum of pseudomonic acid A (1) 
Carbon 
HrO: ). , SC (p. p. m. ) AS x 100 (p. p. m. )" AS x 100 (p"p"m. )° 
166.7 3.7 
3 156.5 5.1 
5 74.7 1.7 5.5 
13 71.3 2.3 4.9,9.1,13.7 
7 70.3 2.3 
9' 63.7 2.9 2.9 
II 61.2 7.2 
9 31.5 13.7 
5' 24.6 10.1 
3' 24.8 9.8 
LI -"C. ' "O=]Acctate-enriched. 
` [1.13C, 2H 3]Acetate-enriched. 
the proposed involvement of ß-hydroxy-p-methylglutarate in 
the formation of both the Cs and C moieties and the origin of 
the C-15 methyl from the methyl carbon of a cleaved acetate 
unit. This feature has been observed more recently in the 
biosynthesis of virginiamycin, 4 myxovirescin, ̀  and myxopy- 
ronin ° but no satisfactory biosynthetic explanation has been 
established as yet. 
A number of incorporation experiments with precursors 
labelled with stable isotopes which provide more information 
on the biosynthetic pathway to pseudomonic acid are now 
reported. 
The ' IC n. m. r. spectrum of pseudomonic acid has been 
rigorously assigned. ' Incorporations of [I-'3C. 'BO2]- and 
[I-13C, 2H3]-acetates and analysis of the enriched metabolites 
by highfield "C n. m. r. (Table) revealed the origins of the 
hydrogen, and more importantly, the oxygen atoms indicated 
in Scheme 2. The oxygens attached to C-I, C-5. C-7, C-13, and 
C-9' are all derived from acetate. Of a number of biogenetic- 
ally reasonable mechanisms which can be proposed for the 
formation of the tetrahydropyran moiety (Scheme 3) only path 
(a) is consistent with the oxygen-labelling results. These results 
also confirm that the ester linkage in pseudomonic acid 
is 
formed eia separate C17 and C9 moieties (Scheme 4) and not via 




Me 0 Me 0 
Scheme 4. 








" t3C or 14C 
Scheme 5. Reagents: i. (BuO)3PO, retlux: ii. CH;. CHCH1Br. Mg. 
tetrahydrofuran. Et20; iii, OP HOAc. CH: CI2: iv. 1-1=02. HOAc 
The proposed involvement of ß-hydroxy-ß-methylglutaric 
acid has been tested by the synthesis" of [3-'4C]- and [3,6- 
'3C2]-ß-hydroxy-ß-methylglutarates (Scheme 5). The "C- 
labelled precursor was incorporated with high efficiency into 
pseudomonic acid (dilution value' 7.2). However, analysis of 
the "C n. m. r. spectrum of the metabolite derived from the 
"C2-labelled precursor, showed 13C_1 3C coupling satellites 
throughout the molecule. con istent with incorporation of label 
from the glutarate entirely eia prior breakdown to acetyl 
coenzyme A and subsequent re-incorporation. There was no 
evidence whatsoever for the preferential enrichments of C-3 and 
C-4 or C-7' required by the pathway shown in Scheme I. 
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